,Unnamed: 0,Patient ID,Sample ID,Diagnosis Age,Aneuploidy Score,Buffa Hypoxia Score,Last Communication Contact from Initial Pathologic Diagnosis Date,Birth from Initial Pathologic Diagnosis Date,Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value,Disease Free (Months),Disease Free Status,Ethnicity Category,Fraction Genome Altered,Neoadjuvant Therapy Type Administered Prior To Resection Text,"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code",In PanCan Pathway Analysis,MSI MANTIS Score,MSIsensor Score,Mutation Count,New Neoplasm Event Post Initial Therapy Indicator,Overall Survival (Months),Overall Survival Status,Other Patient ID,Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code,American Joint Committee on Cancer Tumor Stage Code,Person Neoplasm Cancer Status,Progress Free Survival (Months),Progression Free Status,Prior Diagnosis,Race Category,Radiation Therapy,Ragnum Hypoxia Score,Subtype,Tissue Prospective Collection Indicator,Tissue Retrospective Collection Indicator,Tissue Source Site,Tissue Source Site Code,TMB (nonsynonymous),Tumor Type,Winter Hypoxia Score
19,297,TCGA-KC-A7F5,TCGA-KC-A7F5-01,54,,,91.0,-20015.0,0.0,2.991748036,0,0,,No,8140/3,No,0.3311,0.0,30.0,No,2.991748036,0:LIVING,3A6E0FD1-6E06-4002-9D1A-88EDF7944567,N0,T2C,Tumor Free,2.991748036,0:CENSORED,No,,No,,,No,Yes,Cornell Medical College,KC,1.0,"Prostate Adenocarcinoma, Acinar Type",
23,101,TCGA-EJ-7793,TCGA-EJ-7793-01,49,0.0,-29.0,114.0,-17982.0,0.0,3.747904133,0,1,0.0031,No,8550/3,Yes,0.3176,0.0,11.0,,3.747904133,0:LIVING,da07da37-bde6-480a-a302-98683ae3931a,,T2C,Tumor Free,3.747904133,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.366666667,"Prostate Adenocarcinoma, Acinar Type",-42.0
25,137,TCGA-EJ-AB20,TCGA-EJ-AB20-01,61,2.0,,131.0,-22626.0,0.0,4.306802117,0,0,0.0543,No,8140/3,Yes,0.3281,0.06,13.0,No,4.306802117,0:LIVING,743FFC51-D613-407F-B040-E99969C31802,N0,T2C,Tumor Free,4.306802117,0:CENSORED,No,,No,,PRAD,Yes,No,University of Pittsburgh,EJ,0.433333333,"Prostate Adenocarcinoma, Acinar Type",
26,493,TCGA-ZG-A9NI,TCGA-ZG-A9NI-01,73,7.0,,132.0,-26697.0,0.0,4.339678469,0,0,0.2181,No,8140/3,Yes,0.3079,0.0,83.0,No,4.339678469,0:LIVING,03C15D06-B81E-433C-9DE4-906CBA91539F,N0,T3B,Tumor Free,4.339678469,0:CENSORED,No,,No,,PRAD,No,Yes,University Medical Center Hamburg-Eppendorf,ZG,2.766666667,"Prostate Adenocarcinoma, Acinar Type",
28,136,TCGA-EJ-A8FU,TCGA-EJ-A8FU-01,64,0.0,-31.0,138.0,-23472.0,0.0,4.536936582,0,0,0.0,No,8140/3,Yes,0.3166,0.0,8.0,No,4.536936582,0:LIVING,23E56E08-E11D-4E83-88A8-1254675B3AF8,N0,T3A,Tumor Free,4.536936582,0:CENSORED,No,,No,-24.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.266666667,"Prostate Adenocarcinoma, Acinar Type",-40.0
29,138,TCGA-EJ-AB27,TCGA-EJ-AB27-01,51,1.0,,145.0,-18648.0,0.0,4.767071046,0,0,0.0001,No,8140/3,Yes,0.3237,0.0,15.0,No,4.767071046,0:LIVING,B7B61392-C085-4E28-892F-E9B6FE6ECE41,N0,T2C,Tumor Free,4.767071046,0:CENSORED,No,,No,,PRAD,Yes,No,University of Pittsburgh,EJ,0.5,"Prostate Adenocarcinoma, Acinar Type",
33,355,TCGA-MG-AAMC,TCGA-MG-AAMC-01,59,3.0,,173.0,-21846.0,0.0,5.687608903,0,0,0.0697,No,8140/3,Yes,0.3368,0.05,22.0,,5.687608903,0:LIVING,9C8447AC-5B26-4558-8BFD-F0E7046C1FB9,N0,T3A,Tumor Free,5.687608903,0:CENSORED,No,,No,,PRAD,No,Yes,BLN - Baylor,MG,0.733333333,"Prostate Adenocarcinoma, Acinar Type",
35,399,TCGA-VN-A88M,TCGA-VN-A88M-01,55,0.0,,189.0,-20157.0,0.0,6.213630536,0,0,0.056,No,8140/3,Yes,0.3158,0.0,16.0,,6.213630536,0:LIVING,35243518-B086-4D76-A336-8C61A14F9DED,N0,T2C,Tumor Free,6.213630536,0:CENSORED,No,,No,,PRAD,No,Yes,NCI Urologic Oncology Branch,VN,0.533333333,"Prostate Adenocarcinoma, Acinar Type",
38,131,TCGA-EJ-A7NN,TCGA-EJ-A7NN-01,61,,,197.0,-22499.0,0.0,6.476641352,1,0,,No,8140/3,No,0.3318,0.0,32.0,No,6.476641352,0:LIVING,C8FAB4A7-FD7E-4D5E-A330-18C7E148B9D0,N1,T3B,Tumor Free,6.476641352,1:PROGRESSION,No,,No,,,Yes,No,University of Pittsburgh,EJ,1.066666667,"Prostate Adenocarcinoma, Acinar Type",
39,128,TCGA-EJ-A7NJ,TCGA-EJ-A7NJ-01,59,0.0,-31.0,197.0,-21748.0,0.0,6.476641352,0,0,0.0,No,8140/3,Yes,0.3221,0.0,8.0,No,6.476641352,0:LIVING,F6743FF8-542E-4FDE-8FF2-4878FCABFFDA,N0,T2C,Tumor Free,6.476641352,0:CENSORED,No,,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.266666667,"Prostate Adenocarcinoma, Acinar Type",-40.0
40,377,TCGA-V1-A8X3,TCGA-V1-A8X3-01,51,1.0,-35.0,202.0,-18980.0,,6.641023112,0,0,0.0612,No,8140/3,Yes,0.3208,0.0,22.0,No,6.641023112,0:LIVING,86B82965-B19B-4285-B1A5-51A5D5267103,N0,T2C,,6.641023112,0:CENSORED,No,,No,-20.0,PRAD,No,Yes,University of California San Francisco,V1,0.733333333,"Prostate Adenocarcinoma, Acinar Type",-38.0
41,12,TCGA-CH-5738,TCGA-CH-5738-01,72,0.0,-35.0,212.0,-26329.0,0.0,6.969786633,0,1,0.0011,No,8550/3,Yes,0.2594,0.0,15.0,No,6.969786633,0:LIVING,5828401b-0901-4a73-9d0c-1e85d3431475,,,Tumor Free,6.969786633,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,Indivumed,CH,0.5,"Prostate Adenocarcinoma, Acinar Type",-46.0
43,122,TCGA-EJ-A65M,TCGA-EJ-A65M-01,65,0.0,,230.0,-23767.0,0.0,7.561560969,0,0,0.075,No,8140/3,Yes,0.311,0.0,31.0,No,7.561560969,0:LIVING,D4FF9F1A-1D35-4AD6-9A36-059547081C7E,N0,T2C,Tumor Free,7.561560969,0:CENSORED,No,,No,,PRAD,Yes,No,University of Pittsburgh,EJ,1.066666667,"Prostate Adenocarcinoma, Acinar Type",
44,298,TCGA-KC-A7F6,TCGA-KC-A7F6-01,63,2.0,-29.0,263.0,-23367.0,0.0,8.646480587,0,0,0.0466,No,8140/3,Yes,0.3256,0.0,22.0,No,8.646480587,0:LIVING,FC823AB7-9390-4C57-9883-3E32EE17E794,N0,T2C,Tumor Free,8.646480587,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,Cornell Medical College,KC,0.733333333,"Prostate Adenocarcinoma, Acinar Type",-16.0
45,135,TCGA-EJ-A8FS,TCGA-EJ-A8FS-01,66,2.0,-27.0,266.0,-24380.0,0.0,7.101292041,1,0,0.0934,No,8140/3,Yes,0.3282,0.0,28.0,No,8.745109643,0:LIVING,9044098B-415D-4893-A682-3636F6B2B2DB,N0,T3A,With Tumor,7.101292041,1:PROGRESSION,No,,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.933333333,"Prostate Adenocarcinoma, Acinar Type",-38.0
47,300,TCGA-KC-A7FD,TCGA-KC-A7FD-01,62,1.0,-15.0,270.0,-22745.0,0.0,8.876615051,0,0,0.0153,No,8140/3,Yes,0.3307,0.0,38.0,No,8.876615051,0:LIVING,88658B66-F293-4AFF-9E33-05ABFAFD3B43,N0,T3A,Tumor Free,8.876615051,0:CENSORED,No,,No,-20.0,PRAD,No,Yes,Cornell Medical College,KC,1.266666667,"Prostate Adenocarcinoma, Acinar Type",2.0
49,133,TCGA-EJ-A8FO,TCGA-EJ-A8FO-01,51,0.0,,282.0,-18875.0,0.0,9.271131275,0,0,0.0,No,8500/3,No,0.3206,0.0,15.0,No,9.271131275,0:LIVING,B751083D-BE6D-45DA-BE97-A6D41D8EBE97,N0,T3A,Tumor Free,9.271131275,0:CENSORED,No,,No,,,Yes,No,University of Pittsburgh,EJ,0.5,"Prostate Adenocarcinoma, Other Subtype",
51,134,TCGA-EJ-A8FP,TCGA-EJ-A8FP-01,59,0.0,,299.0,-21769.0,0.0,3.846533189,1,0,0.0001,No,8500/3,No,0.3209,0.0,8.0,No,9.83002926,0:LIVING,00F0F7DD-71DE-4E4F-B4B5-DF860324F2E8,N0,T2C,With Tumor,3.846533189,1:PROGRESSION,No,,No,,,Yes,No,University of Pittsburgh,EJ,0.266666667,"Prostate Adenocarcinoma, Other Subtype",
52,38,TCGA-CH-5789,TCGA-CH-5789-01,61,0.0,-27.0,304.0,-22494.0,0.0,9.99441102,0,1,0.0,No,8550/3,Yes,0.2699,0.02,3.0,No,9.99441102,0:LIVING,be5411dc-3caa-4b25-9b94-ce463e8e52b4,N0,T3A,Tumor Free,9.99441102,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,Indivumed,CH,0.1,"Prostate Adenocarcinoma, Acinar Type",-30.0
55,275,TCGA-J4-A83K,TCGA-J4-A83K-01,52,0.0,-27.0,328.0,-19299.0,0.0,10.78344347,0,0,0.0005,No,8140/3,Yes,0.3236,0.0,23.0,No,10.78344347,0:LIVING,256F5BCF-10A9-47BE-B265-CFA707D24097,,T2C,Tumor Free,10.78344347,0:CENSORED,No,,No,-20.0,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.766666667,"Prostate Adenocarcinoma, Acinar Type",-32.0
56,132,TCGA-EJ-A8FN,TCGA-EJ-A8FN-01,58,2.0,-27.0,329.0,-21506.0,0.0,10.81631982,0,0,0.0836,No,8140/3,Yes,0.3157,0.0,32.0,No,10.81631982,0:LIVING,EA770D22-2CBA-465C-9555-E0877DCECB9F,N0,T2C,Tumor Free,10.81631982,0:CENSORED,No,,No,-24.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.1,"Prostate Adenocarcinoma, Acinar Type",-36.0
57,10,TCGA-4L-AA1F,TCGA-4L-AA1F-01,64,14.0,,350.0,-23665.0,0.0,11.50672321,0,0,0.1387,No,8140/3,Yes,0.3414,0.05,25.0,No,11.50672321,0:LIVING,47ABCD03-C6FF-4777-AC26-F880474092FF,N0,T3B,Tumor Free,11.50672321,0:CENSORED,No,,No,,PRAD,Yes,No,"Proteogenex, Inc.",4L,0.833333333,"Prostate Adenocarcinoma, Acinar Type",
58,301,TCGA-KC-A7FE,TCGA-KC-A7FE-01,62,,-37.0,352.0,-22718.0,0.0,11.57247592,0,0,0.0,No,8140/3,Yes,0.3344,0.0,7.0,No,11.57247592,0:LIVING,7C40C747-5000-4F66-AAB5-C53FB96337CB,N0,T2C,Tumor Free,11.57247592,0:CENSORED,No,,No,-26.0,PRAD,No,Yes,Cornell Medical College,KC,0.233333333,"Prostate Adenocarcinoma, Acinar Type",-26.0
61,28,TCGA-CH-5763,TCGA-CH-5763-01,66,,-31.0,365.0,-24380.0,0.0,11.9998685,0,1,0.0,No,8550/3,Yes,0.2624,0.0,16.0,No,11.9998685,0:LIVING,18e79a01-07a2-4cd5-b700-71d41724e041,N0,T3A,Tumor Free,11.9998685,0:CENSORED,Yes,White,No,-16.0,PRAD,Yes,No,Indivumed,CH,0.533333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
62,422,TCGA-XA-A8JR,TCGA-XA-A8JR-01,68,0.0,-31.0,376.0,-25090.0,0.0,12.36150837,0,0,0.0302,No,8140/3,Yes,0.3025,0.0,20.0,No,12.36150837,0:LIVING,5E15DCC7-932E-4D9A-A765-BD5FF1CD7AEA,N0,T2C,Tumor Free,12.36150837,0:CENSORED,No,,No,-20.0,PRAD,Yes,No,University of Minnesota,XA,0.7,"Prostate Adenocarcinoma, Acinar Type",-32.0
63,483,TCGA-ZG-A9LM,TCGA-ZG-A9LM-01,72,11.0,,378.0,-26377.0,0.0,12.42726107,0,0,0.3341,No,8140/3,Yes,0.3418,0.02,30.0,No,12.42726107,0:LIVING,9357E8EB-1CE5-4C0F-A668-E5E7F3031D6C,N1,T3A,Tumor Free,12.42726107,0:CENSORED,No,,No,,PRAD,No,Yes,University Medical Center Hamburg-Eppendorf,ZG,1.0,"Prostate Adenocarcinoma, Acinar Type",
64,349,TCGA-M7-A720,TCGA-M7-A720-01,53,0.0,-31.0,384.0,-19642.0,0.0,12.62451918,0,0,0.0,No,8140/3,Yes,0.312,0.0,6.0,No,12.62451918,0:LIVING,444E78F7-1221-4882-ADE2-7E45D828EA2A,,T2C,Tumor Free,12.62451918,0:CENSORED,No,,No,-18.0,PRAD,Yes,No,University of North Carolina,M7,0.2,"Prostate Adenocarcinoma, Acinar Type",-42.0
65,290,TCGA-J9-A8CP,TCGA-J9-A8CP-01,66,1.0,-27.0,386.0,-24299.0,0.0,12.69027189,0,0,0.1271,No,8140/3,Yes,0.3121,0.0,27.0,No,12.69027189,0:LIVING,5B12458B-F5D7-41DE-A4E1-26D39DCA9B17,,T3A,Tumor Free,12.69027189,0:CENSORED,No,,No,-22.0,PRAD,Yes,No,Melbourne Health,J9,0.9,"Prostate Adenocarcinoma, Acinar Type",-30.0
66,117,TCGA-EJ-A65D,TCGA-EJ-A65D-01,66,2.0,,393.0,-24297.0,0.0,12.92040635,0,0,0.1029,No,8500/3,Yes,0.314,0.01,35.0,No,12.92040635,0:LIVING,8E1FF72B-F1DB-4BF9-A8D3-F422E25A65E1,N0,T3A,Tumor Free,12.92040635,0:CENSORED,No,,No,,PRAD,Yes,No,University of Pittsburgh,EJ,1.166666667,"Prostate Adenocarcinoma, Other Subtype",
67,15,TCGA-CH-5741,TCGA-CH-5741-01,56,0.0,-25.0,395.0,-20759.0,0.0,12.98615906,0,1,0.0576,No,8550/3,Yes,0.2602,0.04,21.0,No,12.98615906,0:LIVING,b3bf57d4-e31a-4740-b438-fa826fb79550,N1,T3B,Tumor Free,12.98615906,0:CENSORED,No,White,Yes,-18.0,PRAD,Yes,No,Indivumed,CH,0.7,"Prostate Adenocarcinoma, Acinar Type",-44.0
68,350,TCGA-M7-A721,TCGA-M7-A721-01,70,0.0,-17.0,400.0,-25585.0,0.0,13.15054082,0,0,0.0558,No,8140/3,Yes,0.3164,0.04,29.0,,13.15054082,0:LIVING,6433F001-DB5C-476B-83C7-23F4C5397AE9,,T2C,Tumor Free,13.15054082,0:CENSORED,No,,No,-22.0,PRAD,Yes,No,University of North Carolina,M7,0.966666667,"Prostate Adenocarcinoma, Acinar Type",-32.0
71,46,TCGA-EJ-5497,TCGA-EJ-5497-01,47,0.0,-37.0,405.0,-17523.0,0.0,13.31492258,0,1,0.0283,No,8550/3,Yes,0.26,0.0,17.0,,13.31492258,0:LIVING,dee02265-d8dd-4379-ae08-72d72b03a570,N0,T2C,Tumor Free,13.31492258,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.6,"Prostate Adenocarcinoma, Acinar Type",-38.0
72,492,TCGA-ZG-A9ND,TCGA-ZG-A9ND-01,55,2.0,,410.0,-20428.0,0.0,13.47930434,0,0,0.167,No,8140/3,Yes,0.3249,0.0,25.0,No,13.47930434,0:LIVING,348C2BF3-2146-4990-9ADF-FA6968B4F072,N0,T3A,Tumor Free,13.47930434,0:CENSORED,No,,No,,PRAD,No,Yes,University Medical Center Hamburg-Eppendorf,ZG,0.833333333,"Prostate Adenocarcinoma, Acinar Type",
73,280,TCGA-J4-AATZ,TCGA-J4-AATZ-01,66,1.0,,412.0,-24226.0,0.0,2.597231811,1,0,0.1118,No,8140/3,Yes,0.3366,0.0,35.0,Yes,13.54505704,0:LIVING,73B7D4BC-6B56-4AE8-BE7F-074745563BEE,N0,T3A,With Tumor,2.597231811,1:PROGRESSION,No,,Yes,,PRAD,Yes,No,ABS - Lahey Clinic,J4,1.166666667,"Prostate Adenocarcinoma, Acinar Type",
74,118,TCGA-EJ-A65E,TCGA-EJ-A65E-01,67,1.0,-21.0,417.0,-24558.0,0.0,13.7094388,0,0,0.0394,No,8255/3,Yes,0.3002,0.01,33.0,No,13.7094388,0:LIVING,37EC45FD-1C85-49CB-835E-FA7B2B8CE16F,N0,T3B,Tumor Free,13.7094388,0:CENSORED,No,,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.066666667,"Prostate Adenocarcinoma, Other Subtype",-30.0
75,282,TCGA-J9-A52B,TCGA-J9-A52B-01,62,5.0,-25.0,422.0,-22849.0,0.0,1.873952066,1,0,0.0615,No,8550/3,Yes,0.2999,0.05,35.0,Yes,13.87382056,0:LIVING,2ECCAABE-0783-4596-B674-D59846373A1D,N0,T3B,,1.873952066,1:PROGRESSION,No,,No,-22.0,PRAD,No,Yes,Melbourne Health,J9,1.133333333,"Prostate Adenocarcinoma, Acinar Type",-32.0
76,16,TCGA-CH-5743,TCGA-CH-5743-01,66,,-35.0,425.0,-24321.0,0.0,13.97244962,0,1,0.0,No,8550/3,No,0.2748,0.0,,Yes,13.97244962,0:LIVING,2dee4bd8-b00e-4f8a-bfea-5d8d1a068202,N0,T2C,Tumor Free,13.97244962,1:PROGRESSION,No,White,No,-18.0,,Yes,No,Indivumed,CH,0.0,"Prostate Adenocarcinoma, Acinar Type",-36.0
77,126,TCGA-EJ-A7NG,TCGA-EJ-A7NG-01,64,0.0,-35.0,432.0,-23458.0,0.0,14.20258408,0,0,0.0,No,8140/3,Yes,0.3218,0.0,2.0,No,14.20258408,0:LIVING,607FD22B-F281-431B-848E-AE01E69567E2,N0,T3A,Tumor Free,14.20258408,0:CENSORED,No,,No,-24.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.066666667,"Prostate Adenocarcinoma, Acinar Type",-30.0
78,198,TCGA-HC-7209,TCGA-HC-7209-01,60,0.0,-33.0,440.0,-22129.0,0.0,14.4655949,0,1,0.0422,No,8550/3,Yes,0.3354,0.0,15.0,No,14.4655949,0:LIVING,582d1177-73b0-4a9c-8505-70d6b402bd01,N0,T2C,Tumor Free,14.4655949,0:CENSORED,No,White,No,-14.0,PRAD,Yes,No,International Genomics Consortium,HC,0.533333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
80,369,TCGA-V1-A8ML,TCGA-V1-A8ML-01,63,1.0,-25.0,448.0,-23360.0,,14.72860571,0,0,0.0045,No,8140/3,Yes,0.3314,0.0,10.0,No,14.72860571,0:LIVING,69174712-AF41-422D-952A-D8D0D16D7182,N0,T2C,,14.72860571,0:CENSORED,No,,No,-28.0,PRAD,No,Yes,University of California San Francisco,V1,0.333333333,"Prostate Adenocarcinoma, Acinar Type",-32.0
81,419,TCGA-WW-A8ZI,TCGA-WW-A8ZI-01,70,2.0,-33.0,449.0,-25593.0,0.0,14.76148207,0,0,0.0819,No,8140/3,Yes,0.3274,0.0,26.0,No,14.76148207,0:LIVING,ABEB0894-862F-4035-A6D9-FE0BA61630A9,N0,T2C,Tumor Free,14.76148207,0:CENSORED,No,,No,-22.0,PRAD,Yes,No,Wake Forest University,WW,0.866666667,"Prostate Adenocarcinoma, Acinar Type",-36.0
82,121,TCGA-EJ-A65J,TCGA-EJ-A65J-01,62,0.0,-15.0,451.0,-22904.0,0.0,14.82723477,0,0,0.078,No,8140/3,Yes,0.3196,0.0,31.0,No,14.82723477,0:LIVING,89C150CF-F60C-4F11-8F3E-384B0E0902F9,N0,T3A,Tumor Free,14.82723477,0:CENSORED,Yes,,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.033333333,"Prostate Adenocarcinoma, Acinar Type",-32.0
85,127,TCGA-EJ-A7NH,TCGA-EJ-A7NH-01,56,4.0,-31.0,474.0,-20734.0,0.0,15.58339087,0,0,0.0822,No,8140/3,Yes,0.3335,0.05,19.0,No,15.58339087,0:LIVING,0D498226-E22A-44A4-9EF8-1DA8E83FA55B,N0,T2C,Tumor Free,15.58339087,0:CENSORED,No,,No,-18.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.633333333,"Prostate Adenocarcinoma, Acinar Type",-34.0
88,129,TCGA-EJ-A7NK,TCGA-EJ-A7NK-01,58,0.0,-35.0,476.0,-21530.0,0.0,15.64914357,0,0,0.0001,No,8140/3,Yes,0.3182,0.04,4.0,No,15.64914357,0:LIVING,C362F6F9-4CE6-4659-8C36-4CD45C72FB03,N0,T3A,Tumor Free,15.64914357,0:CENSORED,No,,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.133333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
89,401,TCGA-VN-A88O,TCGA-VN-A88O-01,49,2.0,-19.0,481.0,-17945.0,0.0,15.81352533,0,0,0.0666,No,8140/3,Yes,0.3181,0.0,29.0,,15.81352533,0:LIVING,EB715348-7C5C-4E95-BAC8-05604BDDA2DA,N0,T2C,Tumor Free,15.81352533,0:CENSORED,No,,No,-20.0,PRAD,No,Yes,NCI Urologic Oncology Branch,VN,0.966666667,"Prostate Adenocarcinoma, Acinar Type",-22.0
90,234,TCGA-HC-8265,TCGA-HC-8265-01,66,1.0,-19.0,483.0,-24382.0,0.0,15.87927804,0,0,0.1478,No,8550/3,Yes,0.3432,2.05,52.0,No,15.87927804,0:LIVING,3e290dc6-aba3-4135-b844-3e8c4cc8a25f,N0,T3A,With Tumor,15.87927804,0:CENSORED,No,,Yes,-24.0,PRAD,Yes,No,International Genomics Consortium,HC,1.766666667,"Prostate Adenocarcinoma, Acinar Type",-22.0
91,36,TCGA-CH-5772,TCGA-CH-5772-01,63,0.0,-35.0,486.0,-23194.0,0.0,15.97790709,0,1,0.0255,No,8550/3,Yes,0.2662,0.0,46.0,No,15.97790709,0:LIVING,ecf9f8be-7830-4626-8617-694c68ef4074,N0,T3A,Tumor Free,15.97790709,0:CENSORED,Yes,White,Yes,-18.0,PRAD,Yes,No,Indivumed,CH,1.533333333,"Prostate Adenocarcinoma, Acinar Type",-32.0
92,405,TCGA-VN-A943,TCGA-VN-A943-01,71,0.0,,496.0,-26162.0,0.0,16.30667061,0,0,0.0399,No,8140/3,Yes,0.3218,0.0,22.0,No,16.30667061,0:LIVING,92F45022-EE76-418D-8F9E-C3509EFDA0C0,N0,T2C,Tumor Free,16.30667061,0:CENSORED,No,,No,,PRAD,No,Yes,NCI Urologic Oncology Branch,VN,0.733333333,"Prostate Adenocarcinoma, Acinar Type",
93,368,TCGA-V1-A8MK,TCGA-V1-A8MK-01,41,,,508.0,-15330.0,,16.70118684,0,0,0.0,No,8140/3,No,0.3185,0.0,8.0,No,16.70118684,0:LIVING,9938C4AD-748C-4086-9081-FAC0AEFAD440,N0,T2C,,16.70118684,0:CENSORED,No,,No,,,No,Yes,University of California San Francisco,V1,0.3,"Prostate Adenocarcinoma, Acinar Type",
94,272,TCGA-J4-A6M7,TCGA-J4-A6M7-01,53,0.0,-33.0,512.0,-19640.0,0.0,16.83269224,0,0,0.0036,No,8140/3,Yes,0.3215,0.0,12.0,No,16.83269224,0:LIVING,F00B4A22-C327-4FBB-A9A3-4418C13E2A48,,T2C,Tumor Free,16.83269224,0:CENSORED,No,,No,-20.0,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.4,"Prostate Adenocarcinoma, Acinar Type",-42.0
96,485,TCGA-ZG-A9LS,TCGA-ZG-A9LS-01,64,7.0,,516.0,-23540.0,0.0,16.96419765,0,0,0.1958,No,8140/3,Yes,0.3278,0.0,18.0,No,16.96419765,0:LIVING,AFA7D9A2-3998-4182-BF63-54895ED2DE37,N1,T3B,With Tumor,16.96419765,0:CENSORED,No,,Yes,,PRAD,No,Yes,University Medical Center Hamburg-Eppendorf,ZG,0.6,"Prostate Adenocarcinoma, Acinar Type",
97,111,TCGA-EJ-A46E,TCGA-EJ-A46E-01,57,,,524.0,-21054.0,0.0,17.22720847,0,0,0.0,No,8140/3,Yes,0.3085,0.0,5.0,,17.22720847,0:LIVING,A608BF0E-A932-4541-8439-2FFB9F6294B0,N0,,Tumor Free,17.22720847,0:CENSORED,No,,No,,PRAD,Yes,No,University of Pittsburgh,EJ,0.166666667,"Prostate Adenocarcinoma, Acinar Type",
99,441,TCGA-Y6-A9XI,TCGA-Y6-A9XI-01,72,1.0,,526.0,-26471.0,0.0,17.29296117,0,0,0.0769,No,8140/3,Yes,0.3279,0.0,40.0,No,17.29296117,0:LIVING,C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,N0,,Tumor Free,17.29296117,0:CENSORED,No,,No,,PRAD,No,Yes,University of Arizona,Y6,1.333333333,"Prostate Adenocarcinoma, Acinar Type",
100,242,TCGA-HC-A6AO,TCGA-HC-A6AO-01,52,2.0,,530.0,-19298.0,0.0,17.42446658,0,0,0.1062,No,8140/3,Yes,0.303,0.1,25.0,No,17.42446658,0:LIVING,4045F40B-D42A-4598-9EE2-0D371A776D3F,,T2C,Tumor Free,17.42446658,0:CENSORED,No,,No,,PRAD,Yes,No,International Genomics Consortium,HC,0.833333333,"Prostate Adenocarcinoma, Acinar Type",
101,212,TCGA-HC-7744,TCGA-HC-7744-01,46,0.0,-31.0,531.0,-17065.0,0.0,17.45734293,0,1,0.0174,No,8550/3,Yes,0.3455,0.13,32.0,No,17.45734293,0:LIVING,f6381367-142c-45d0-92b3-c1727d1813ce,N0,T3B,With Tumor,17.45734293,0:CENSORED,No,White,Yes,-12.0,PRAD,Yes,No,International Genomics Consortium,HC,1.066666667,"Prostate Adenocarcinoma, Acinar Type",-30.0
102,391,TCGA-V1-A9Z9,TCGA-V1-A9Z9-01,63,0.0,,540.0,-23360.0,,17.7532301,0,0,0.0623,No,8140/3,Yes,0.322,0.0,28.0,No,17.7532301,0:LIVING,0885EB03-DE9F-46BA-9C53-FB69C67AB9F0,N0,T2C,,17.7532301,0:CENSORED,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.933333333,"Prostate Adenocarcinoma, Acinar Type",
103,277,TCGA-J4-A83M,TCGA-J4-A83M-01,64,0.0,-29.0,543.0,-23624.0,0.0,17.12857941,1,0,0.0102,No,8140/3,Yes,0.3224,0.0,30.0,Yes,17.85185916,0:LIVING,D6974DB6-2BD3-4082-B48E-9C60F7FE3A1F,N0,T2C,,17.12857941,1:PROGRESSION,No,,Yes,-18.0,PRAD,Yes,No,ABS - Lahey Clinic,J4,1.0,"Prostate Adenocarcinoma, Acinar Type",-32.0
104,221,TCGA-HC-7819,TCGA-HC-7819-01,53,1.0,,543.0,-19663.0,0.0,17.85185916,0,1,0.0674,No,8550/3,Yes,0.3362,0.0,24.0,No,17.85185916,0:LIVING,d1fd7be0-6daa-4f1f-a198-3dca7a797e49,N0,T2C,With Tumor,17.85185916,0:CENSORED,No,White,No,,PRAD,Yes,No,International Genomics Consortium,HC,1.566666667,"Prostate Adenocarcinoma, Acinar Type",
105,231,TCGA-HC-8261,TCGA-HC-8261-01,48,0.0,-27.0,546.0,-17874.0,0.0,17.95048821,0,0,0.0679,No,8550/3,Yes,0.3571,1.06,20.0,No,17.95048821,0:LIVING,f16ce517-d51d-499a-a4c4-a6844fefa52c,,T2C,Tumor Free,17.95048821,0:CENSORED,No,,No,-18.0,PRAD,Yes,No,International Genomics Consortium,HC,0.666666667,"Prostate Adenocarcinoma, Acinar Type",-26.0
109,354,TCGA-M7-A725,TCGA-M7-A725-01,56,5.0,-13.0,573.0,-20474.0,0.0,18.83814972,0,0,0.1838,No,8140/3,Yes,0.3095,0.11,27.0,No,18.83814972,0:LIVING,FCA0331B-8096-40E8-B292-D438370C37C9,N0,T3B,Tumor Free,18.83814972,0:CENSORED,No,,No,-4.0,PRAD,Yes,No,University of North Carolina,M7,0.9,"Prostate Adenocarcinoma, Acinar Type",-14.0
110,252,TCGA-HC-A8D1,TCGA-HC-A8D1-01,68,0.0,-33.0,573.0,-25137.0,0.0,18.83814972,0,0,0.0108,No,8140/3,Yes,0.3278,0.0,21.0,No,18.83814972,0:LIVING,341940FC-DD2A-485C-A359-D5E5EDB22312,N0,T2C,Tumor Free,18.83814972,0:CENSORED,No,,No,-22.0,PRAD,Yes,No,International Genomics Consortium,HC,0.7,"Prostate Adenocarcinoma, Acinar Type",-42.0
112,224,TCGA-HC-8213,TCGA-HC-8213-01,48,0.0,-29.0,589.0,-17673.0,0.0,19.36417135,0,0,0.0083,No,8550/3,Yes,0.3019,0.0,17.0,No,19.36417135,0:LIVING,53c43d14-2310-41e9-ac43-3cc298404338,,T2C,Tumor Free,19.36417135,0:CENSORED,No,,No,-18.0,PRAD,Yes,No,International Genomics Consortium,HC,0.566666667,"Prostate Adenocarcinoma, Acinar Type",-36.0
113,45,TCGA-EJ-5496,TCGA-EJ-5496-01,59,2.0,-33.0,595.0,-21897.0,0.0,19.56142946,0,1,0.0687,No,8550/3,Yes,0.2588,0.01,31.0,,19.56142946,0:LIVING,6755c231-355f-4cc3-85f1-6306c7f5d44b,N0,T2C,Tumor Free,19.56142946,0:CENSORED,No,White,No,-14.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.033333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
114,299,TCGA-KC-A7FA,TCGA-KC-A7FA-01,63,3.0,-11.0,598.0,-23208.0,0.0,19.66005852,0,0,0.074,No,8140/3,Yes,0.3437,0.0,36.0,No,19.66005852,0:LIVING,3F3128C9-1072-443C-B6AE-8B63166FA9A4,N0,T3A,Tumor Free,19.66005852,0:CENSORED,Yes,,No,-22.0,PRAD,No,Yes,Cornell Medical College,KC,1.266666667,"Prostate Adenocarcinoma, Acinar Type",-22.0
115,192,TCGA-HC-7075,TCGA-HC-7075-01,63,0.0,-33.0,601.0,,0.0,19.75868758,0,1,0.0058,No,8550/3,Yes,0.2898,0.0,30.0,No,19.75868758,0:LIVING,5dd69c3e-9a3d-450c-9f10-10b4d6daeeba,,T2A,Tumor Free,19.75868758,0:CENSORED,No,White,No,-18.0,PRAD,No,Yes,International Genomics Consortium,HC,1.0,"Prostate Adenocarcinoma, Acinar Type",-36.0
116,293,TCGA-KC-A4BO,TCGA-KC-A4BO-01,55,,,607.0,-20368.0,0.0,19.95594569,0,0,0.0002,No,8140/3,No,0.323,0.0,2.0,No,19.95594569,0:LIVING,9A05AA6D-6215-4584-90FC-09A0371A19ED,N0,T2C,Tumor Free,19.95594569,0:CENSORED,No,,No,,,No,Yes,Cornell Medical College,KC,0.066666667,"Prostate Adenocarcinoma, Acinar Type",
118,145,TCGA-FC-A8O0,TCGA-FC-A8O0-01,68,0.0,-37.0,616.0,-25115.0,0.0,20.25183286,0,0,0.0001,No,8140/3,Yes,0.3192,0.0,14.0,No,20.25183286,0:LIVING,7EEA6FD7-733C-44EB-B4B7-50BB3A2628A0,N0,T3A,Tumor Free,20.25183286,0:CENSORED,No,,,-24.0,PRAD,Yes,No,Asterand,FC,0.466666667,"Prostate Adenocarcinoma, Acinar Type",-34.0
121,110,TCGA-EJ-A46D,TCGA-EJ-A46D-01,53,0.0,-29.0,626.0,-19466.0,0.0,20.58059638,0,0,0.0004,No,8140/3,Yes,0.2985,0.0,11.0,No,20.58059638,0:LIVING,93D10D8B-5F98-4D2C-8AF3-11471385D4D4,N0,T2C,Tumor Free,20.58059638,0:CENSORED,No,,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.366666667,"Prostate Adenocarcinoma, Acinar Type",-38.0
123,381,TCGA-V1-A9OA,TCGA-V1-A9OA-01,61,3.0,,636.0,-22630.0,,20.9093599,0,0,0.1664,No,8140/3,Yes,0.3348,0.0,17.0,No,20.9093599,0:LIVING,A8396F6D-53E2-4664-A3E2-DF061D022108,N1,T3B,,20.9093599,0:CENSORED,No,,Yes,,PRAD,No,Yes,University of California San Francisco,V1,0.566666667,"Prostate Adenocarcinoma, Acinar Type",
124,109,TCGA-EJ-A46B,TCGA-EJ-A46B-01,66,0.0,,657.0,-24305.0,0.0,21.59976329,0,0,0.0,No,8140/3,Yes,0.3247,0.0,1.0,No,21.59976329,0:LIVING,1170F449-DFB5-417A-A89B-B2229A2785DB,N0,T3A,Tumor Free,21.59976329,0:CENSORED,Yes,,No,,PRAD,Yes,No,University of Pittsburgh,EJ,0.033333333,"Prostate Adenocarcinoma, Acinar Type",
125,415,TCGA-VP-A87H,TCGA-VP-A87H-01,76,11.0,-17.0,663.0,-28060.0,0.0,21.7970214,0,0,0.3105,No,8140/3,Yes,0.3177,0.0,27.0,No,21.7970214,0:LIVING,661DC657-D2B3-44FA-B859-2C4EE42B0046,N0,T3B,With Tumor,21.7970214,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,Washington University,VP,0.9,"Prostate Adenocarcinoma, Acinar Type",-10.0
126,296,TCGA-KC-A7F3,TCGA-KC-A7F3-01,67,0.0,-17.0,665.0,-24676.0,0.0,21.86277411,0,0,0.0563,No,8140/3,Yes,0.3208,0.0,23.0,No,21.86277411,0:LIVING,827CAF2C-A94B-4EEE-86B3-1155A16DAF4A,N0,T2C,Tumor Free,21.86277411,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,Cornell Medical College,KC,0.766666667,"Prostate Adenocarcinoma, Acinar Type",-4.0
127,120,TCGA-EJ-A65G,TCGA-EJ-A65G-01,57,0.0,-29.0,666.0,-20821.0,0.0,21.89565046,0,0,0.0,No,8140/3,Yes,0.3127,0.0,19.0,No,21.89565046,0:LIVING,8BFAC5B9-FA2B-4B6E-9537-E9D8A2F0D1DC,N0,T2C,Tumor Free,21.89565046,0:CENSORED,No,,No,-24.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.633333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
128,115,TCGA-EJ-A46I,TCGA-EJ-A46I-01,57,,-39.0,668.0,-21046.0,0.0,21.96140316,0,0,0.0,No,8140/3,Yes,0.3214,0.0,8.0,No,21.96140316,0:LIVING,9B59ED95-E97F-4356-B976-E3FA0E9EEE02,N0,T3A,Tumor Free,21.96140316,0:CENSORED,No,,No,-24.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.233333333,"Prostate Adenocarcinoma, Acinar Type",-42.0
129,331,TCGA-KK-A8I6,TCGA-KK-A8I6-01,58,0.0,-21.0,668.0,-21499.0,0.0,21.96140316,0,0,0.061,No,8140/3,Yes,0.3292,0.0,23.0,No,21.96140316,0:LIVING,6E3154D4-2EF6-403D-9DE1-7B6233C4D505,N0,T3A,Tumor Free,21.96140316,0:CENSORED,No,,No,-16.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,0.766666667,"Prostate Adenocarcinoma, Acinar Type",-28.0
130,113,TCGA-EJ-A46G,TCGA-EJ-A46G-01,71,2.0,-35.0,668.0,-26219.0,0.0,21.96140316,0,0,0.2006,No,8500/3,Yes,0.2991,0.03,48.0,No,21.96140316,0:LIVING,969399CD-47B6-4C0F-8939-3860BE3014F9,N0,T3A,Tumor Free,21.96140316,0:CENSORED,Yes,,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.566666667,"Prostate Adenocarcinoma, Other Subtype",-42.0
131,236,TCGA-HC-A48F,TCGA-HC-A48F-01,47,5.0,-29.0,680.0,-17434.0,0.0,22.35591939,0,0,0.3399,No,8140/3,Yes,0.3415,0.11,19.0,No,22.35591939,0:LIVING,FF49E0F9-4007-4761-845E-B676B0FC9646,N1,T2C,With Tumor,22.35591939,0:CENSORED,No,,Yes,-12.0,PRAD,Yes,No,International Genomics Consortium,HC,0.633333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
133,225,TCGA-HC-8216,TCGA-HC-8216-01,58,5.0,-21.0,682.0,-21428.0,0.0,22.42167209,0,0,0.0667,No,8550/3,Yes,0.31,0.01,98.0,No,22.42167209,0:LIVING,89afdebe-456e-4128-8902-1001876a2106,N0,T3A,Tumor Free,22.42167209,0:CENSORED,No,,No,-18.0,PRAD,Yes,No,International Genomics Consortium,HC,3.266666667,"Prostate Adenocarcinoma, Acinar Type",-30.0
134,273,TCGA-J4-A83I,TCGA-J4-A83I-01,63,0.0,-33.0,685.0,-23240.0,0.0,22.52030115,0,0,0.0827,No,8140/3,Yes,0.3164,0.0,21.0,No,22.52030115,0:LIVING,5DC7E186-7E01-4A54-8AE8-350DACE2297B,N0,T3A,Tumor Free,22.52030115,0:CENSORED,No,,No,-14.0,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.7,"Prostate Adenocarcinoma, Acinar Type",-42.0
135,230,TCGA-HC-8260,TCGA-HC-8260-01,43,0.0,-33.0,686.0,-15884.0,0.0,22.5531775,0,0,0.0003,No,8550/3,Yes,0.3018,0.1,9.0,No,22.5531775,0:LIVING,3971a2f0-7263-4cda-aa01-9a2ebb2c2ff2,N0,T2C,With Tumor,22.5531775,0:CENSORED,No,,No,-16.0,PRAD,Yes,No,International Genomics Consortium,HC,0.3,"Prostate Adenocarcinoma, Acinar Type",-42.0
136,375,TCGA-V1-A8WV,TCGA-V1-A8WV-01,52,21.0,-23.0,686.0,-19345.0,,22.5531775,0,0,0.5379,No,8140/3,Yes,0.3198,0.02,39.0,No,22.5531775,0:LIVING,8E5B1D47-7D92-4D28-8186-4176ADA96672,N1,T3B,,22.5531775,0:CENSORED,No,,No,-10.0,PRAD,No,Yes,University of California San Francisco,V1,1.3,"Prostate Adenocarcinoma, Acinar Type",-14.0
139,274,TCGA-J4-A83J,TCGA-J4-A83J-01,68,1.0,,696.0,-24960.0,0.0,22.88194102,0,0,0.1083,No,8140/3,No,0.3343,0.0,41.0,No,22.88194102,0:LIVING,98240F19-BCA7-4001-8AA2-4D790C7C4C53,N0,T2C,,22.88194102,0:CENSORED,No,,No,,,Yes,No,ABS - Lahey Clinic,J4,1.366666667,"Prostate Adenocarcinoma, Acinar Type",
140,210,TCGA-HC-7740,TCGA-HC-7740-01,59,0.0,-35.0,717.0,-21883.0,0.0,23.57234441,0,1,0.0002,No,8550/3,Yes,0.3044,0.98,17.0,No,23.57234441,0:LIVING,91e249a6-b0b0-487e-9fad-0e9f5798dcae,N0,T2C,Tumor Free,23.57234441,0:CENSORED,No,White,No,-22.0,PRAD,Yes,No,International Genomics Consortium,HC,1.133333333,"Prostate Adenocarcinoma, Acinar Type",-44.0
141,276,TCGA-J4-A83L,TCGA-J4-A83L-01,61,0.0,,720.0,-22338.0,0.0,23.67097347,0,0,0.0099,No,8140/3,Yes,0.3289,0.0,14.0,No,23.67097347,0:LIVING,8CC7679D-B963-4B45-B3F8-DCF80EA6CC71,N0,T2C,Tumor Free,23.67097347,0:CENSORED,No,,No,,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.5,"Prostate Adenocarcinoma, Acinar Type",
142,213,TCGA-HC-7745,TCGA-HC-7745-01,65,3.0,,721.0,-24078.0,0.0,23.70384982,0,1,0.1515,No,8550/3,Yes,0.3504,0.0,25.0,No,23.70384982,0:LIVING,6641a298-1dbd-445d-a4ab-95ceb98e1427,N0,T3B,Tumor Free,23.70384982,0:CENSORED,No,White,No,,PRAD,Yes,No,International Genomics Consortium,HC,1.6,"Prostate Adenocarcinoma, Acinar Type",
143,114,TCGA-EJ-A46H,TCGA-EJ-A46H-01,60,0.0,,724.0,-22059.0,0.0,23.80247888,0,0,0.0,No,8140/3,Yes,0.315,0.0,2.0,No,23.80247888,0:LIVING,CEC1D2FF-36E6-497E-892C-B329724B4722,N0,T2C,Tumor Free,23.80247888,0:CENSORED,No,,No,,PRAD,Yes,No,University of Pittsburgh,EJ,0.066666667,"Prostate Adenocarcinoma, Acinar Type",
144,216,TCGA-HC-7749,TCGA-HC-7749-01,70,0.0,-35.0,724.0,-25688.0,0.0,23.80247888,0,1,0.0318,No,8550/3,Yes,0.3303,0.0,49.0,No,23.80247888,0:LIVING,13a63fd0-6c8c-4707-9135-8052f454d1ac,N0,T3A,Tumor Free,23.80247888,0:CENSORED,No,White,No,-18.0,PRAD,Yes,No,International Genomics Consortium,HC,1.6,"Prostate Adenocarcinoma, Acinar Type",-36.0
145,227,TCGA-HC-8257,TCGA-HC-8257-01,70,0.0,-31.0,726.0,-25629.0,0.0,23.86823158,0,0,0.0697,No,8550/3,Yes,0.3115,0.0,39.0,No,23.86823158,0:LIVING,270447ca-19ee-45a2-982e-032325dab05f,N1,T3B,With Tumor,23.86823158,0:CENSORED,No,,No,-18.0,PRAD,Yes,No,International Genomics Consortium,HC,1.3,"Prostate Adenocarcinoma, Acinar Type",-28.0
147,410,TCGA-VP-A879,TCGA-VP-A879-01,70,0.0,-33.0,,-25799.0,0.0,23.93398429,0,0,0.0079,No,8140/3,Yes,0.3134,0.0,40.0,No,23.93398429,1:DECEASED,11882DAC-3BA3-40FA-8AF4-174CBA77881A,N0,T2B,,23.93398429,0:CENSORED,No,,No,-24.0,PRAD,No,Yes,Washington University,VP,1.333333333,"Prostate Adenocarcinoma, Acinar Type",-40.0
148,19,TCGA-CH-5746,TCGA-CH-5746-01,57,0.0,-35.0,731.0,-20941.0,0.0,24.03261334,0,1,0.0125,No,8550/3,Yes,0.2718,0.01,9.0,No,24.03261334,0:LIVING,618272c0-c2ed-4bfb-bb4b-404f0987f822,N0,T2C,Tumor Free,24.03261334,0:CENSORED,No,White,Yes,-20.0,PRAD,Yes,No,Indivumed,CH,0.3,"Prostate Adenocarcinoma, Acinar Type",-42.0
149,467,TCGA-YL-A9WL,TCGA-YL-A9WL-01,59,1.0,,740.0,-21626.0,0.0,24.32850051,1,0,0.1404,No,8140/3,Yes,0.3378,0.04,25.0,Yes,24.32850051,0:LIVING,CFCF057A-00FE-4603-A720-586712B75803,N0,T3A,With Tumor,24.32850051,1:PROGRESSION,No,,Yes,,PRAD,No,Yes,PROCURE Biobank,YL,0.866666667,"Prostate Adenocarcinoma, Acinar Type",
150,90,TCGA-EJ-7331,TCGA-EJ-7331-01,64,0.0,-33.0,742.0,-23458.0,0.0,24.39425321,0,1,0.0322,No,8550/3,Yes,0.348,0.0,24.0,No,24.39425321,0:LIVING,b424b73a-2dfa-473f-ab56-ab382cd1cdef,N0,T2C,Tumor Free,24.39425321,0:CENSORED,No,White,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.6,"Prostate Adenocarcinoma, Acinar Type",-28.0
151,398,TCGA-VN-A88L,TCGA-VN-A88L-01,54,0.0,-21.0,746.0,-20026.0,0.0,24.52575862,0,0,0.0429,No,8140/3,Yes,0.3338,0.0,15.0,No,24.52575862,0:LIVING,74602E83-3EE3-4EE7-B05A-135FBDDDCC5C,N0,T2C,Tumor Free,24.52575862,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,NCI Urologic Oncology Branch,VN,0.5,"Prostate Adenocarcinoma, Acinar Type",-28.0
152,222,TCGA-HC-7820,TCGA-HC-7820-01,72,2.0,-31.0,747.0,-26576.0,0.0,24.55863497,0,1,0.0386,No,8550/3,Yes,0.3476,0.0,30.0,No,24.55863497,0:LIVING,a3cd3599-7c18-491d-be09-6fc7e526c9b1,,T2C,Tumor Free,24.55863497,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,International Genomics Consortium,HC,2.0,"Prostate Adenocarcinoma, Acinar Type",-30.0
153,214,TCGA-HC-7747,TCGA-HC-7747-01,52,0.0,-31.0,748.0,-19188.0,0.0,24.59151133,0,1,0.0652,No,8550/3,Yes,0.3271,0.0,31.0,No,24.59151133,0:LIVING,f25bae1a-8627-46a8-87af-07f82773c68a,N0,T2C,Tumor Free,24.59151133,0:CENSORED,No,White,Yes,-18.0,PRAD,Yes,No,International Genomics Consortium,HC,2.033333333,"Prostate Adenocarcinoma, Acinar Type",-48.0
155,400,TCGA-VN-A88N,TCGA-VN-A88N-01,62,0.0,-23.0,766.0,-22695.0,0.0,25.18328566,0,0,0.0175,No,8140/3,Yes,0.3258,0.0,22.0,No,25.18328566,0:LIVING,E9A4C770-665F-454B-81F7-B8AE3F1E154E,N0,T2C,Tumor Free,25.18328566,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,NCI Urologic Oncology Branch,VN,0.733333333,"Prostate Adenocarcinoma, Acinar Type",-34.0
156,270,TCGA-J4-A6G1,TCGA-J4-A6G1-01,68,0.0,-35.0,769.0,-24945.0,0.0,25.28191472,0,0,0.0006,No,8140/3,Yes,0.3098,0.0,12.0,No,25.28191472,0:LIVING,F9F136A5-3CCB-42B3-BA60-C667FBB0846D,N0,T3A,,25.28191472,0:CENSORED,No,,Yes,-20.0,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.433333333,"Prostate Adenocarcinoma, Acinar Type",-50.0
157,439,TCGA-XQ-A8TB,TCGA-XQ-A8TB-01,67,1.0,-31.0,770.0,-24623.0,0.0,25.31479107,0,0,0.0652,No,8140/3,Yes,0.3204,0.0,24.0,No,25.31479107,0:LIVING,5277F041-F9FB-47C2-83F3-65AD230DD40A,N0,T3B,Tumor Free,25.31479107,0:CENSORED,No,,Yes,-20.0,PRAD,,,University of Sao Paulo,XQ,0.8,"Prostate Adenocarcinoma, Acinar Type",-42.0
158,262,TCGA-J4-A67L,TCGA-J4-A67L-01,54,1.0,,770.0,-20034.0,0.0,25.31479107,0,0,0.0606,No,8140/3,Yes,0.3081,0.04,24.0,No,25.31479107,0:LIVING,29BD2C05-254B-4BB2-AE32-5B328F772441,N0,T3A,Tumor Free,25.31479107,0:CENSORED,No,,No,,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.833333333,"Prostate Adenocarcinoma, Acinar Type",
159,83,TCGA-EJ-7317,TCGA-EJ-7317-01,71,0.0,-27.0,771.0,-26064.0,0.0,25.34766742,0,1,0.0281,No,8550/3,Yes,0.314,0.04,32.0,No,25.34766742,0:LIVING,68fc3693-0910-4ee8-8997-99c6333b65f4,N0,T2C,Tumor Free,25.34766742,0:CENSORED,No,White,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,2.1,"Prostate Adenocarcinoma, Acinar Type",-28.0
160,251,TCGA-HC-A8D0,TCGA-HC-A8D0-01,61,2.0,-29.0,775.0,-22465.0,0.0,25.47917283,0,0,0.0414,No,8140/3,Yes,0.314,0.0,26.0,No,25.47917283,0:LIVING,0AFA0E02-DAAE-47E6-9CCB-9DE8E4FEB73C,N0,T2A,Tumor Free,25.47917283,0:CENSORED,No,,No,-24.0,PRAD,Yes,No,International Genomics Consortium,HC,0.866666667,"Prostate Adenocarcinoma, Acinar Type",-24.0
161,397,TCGA-VN-A88K,TCGA-VN-A88K-01,58,3.0,-19.0,776.0,-21524.0,0.0,25.51204918,0,0,0.1365,No,8140/3,Yes,0.3381,0.03,22.0,No,25.51204918,0:LIVING,A186C956-6756-4339-9793-494FE9B80C94,N1,T3A,,25.51204918,0:CENSORED,No,,No,-24.0,PRAD,No,Yes,NCI Urologic Oncology Branch,VN,0.733333333,"Prostate Adenocarcinoma, Acinar Type",-26.0
162,94,TCGA-EJ-7784,TCGA-EJ-7784-01,63,7.0,-37.0,781.0,-23183.0,0.0,25.67643094,0,1,0.2403,No,8550/3,Yes,0.3355,0.07,36.0,No,25.67643094,0:LIVING,4bc71292-60bb-4b63-86c1-0fe021083804,N0,T2C,Tumor Free,25.67643094,0:CENSORED,No,White,No,-18.0,PRAD,Yes,No,University of Pittsburgh,EJ,2.4,"Prostate Adenocarcinoma, Acinar Type",-52.0
163,218,TCGA-HC-7752,TCGA-HC-7752-01,61,0.0,,782.0,-22366.0,0.0,25.7093073,0,1,0.0251,No,8550/3,Yes,0.3542,0.06,36.0,No,25.7093073,0:LIVING,9b84601b-ee05-4c15-afe3-7bfa7ca5ffac,N0,T2C,Tumor Free,25.7093073,0:CENSORED,No,White,No,,PRAD,Yes,No,International Genomics Consortium,HC,2.233333333,"Prostate Adenocarcinoma, Acinar Type",
166,93,TCGA-EJ-7783,TCGA-EJ-7783-01,70,2.0,-35.0,787.0,-25600.0,0.0,25.87368906,0,1,0.0357,No,8550/3,Yes,0.3263,0.06,37.0,No,25.87368906,0:LIVING,181c6d37-9d8d-4ffa-827b-e3785450ff88,N0,T3A,Tumor Free,25.87368906,0:CENSORED,No,White,No,-14.0,PRAD,Yes,No,University of Pittsburgh,EJ,2.333333333,"Prostate Adenocarcinoma, Acinar Type",-38.0
167,144,TCGA-FC-A6HD,TCGA-FC-A6HD-01,77,0.0,,789.0,-28197.0,0.0,25.93944176,0,0,0.0101,No,8140/3,Yes,0.3288,0.0,25.0,No,25.93944176,0:LIVING,F97FED28-FDF3-4C82-8B6D-1015848B80DC,N0,T3A,,25.93944176,0:CENSORED,No,,No,,PRAD,Yes,No,Asterand,FC,0.866666667,"Prostate Adenocarcinoma, Acinar Type",
168,215,TCGA-HC-7748,TCGA-HC-7748-01,60,1.0,-41.0,792.0,-22072.0,0.0,26.03807082,0,1,0.0414,No,8550/3,Yes,0.3133,0.0,22.0,No,26.03807082,0:LIVING,f6040682-4999-4d71-abc2-354b473c6980,N0,T2A,Tumor Free,26.03807082,0:CENSORED,Yes,White,No,-20.0,PRAD,Yes,No,International Genomics Consortium,HC,0.766666667,"Prostate Adenocarcinoma, Acinar Type",-44.0
170,170,TCGA-G9-6373,TCGA-G9-6373-01,68,7.0,,811.0,-24887.0,0.0,26.6627215,0,1,0.1457,No,8550/3,Yes,0.3311,0.06,21.0,No,26.6627215,0:LIVING,c3a509c6-35a6-4d17-a9fd-0aa8884b33a0,,T3A,Tumor Free,26.6627215,0:CENSORED,No,White,No,,PRAD,No,Yes,Roswell Park,G9,1.4,"Prostate Adenocarcinoma, Acinar Type",
172,390,TCGA-V1-A9Z8,TCGA-V1-A9Z8-01,59,1.0,,827.0,-21900.0,,27.18874314,0,0,0.0943,No,8140/3,Yes,0.3284,0.0,26.0,,27.18874314,0:LIVING,9BF4E7BB-6AA9-4BE8-A7C3-E630ECFF4DCE,N0,T3B,,27.18874314,0:CENSORED,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.866666667,"Prostate Adenocarcinoma, Acinar Type",
173,175,TCGA-G9-6385,TCGA-G9-6385-01,66,0.0,-37.0,830.0,-24399.0,0.0,27.28737219,0,1,0.0,No,8550/3,Yes,0.2929,0.0,9.0,No,27.28737219,0:LIVING,e82a04cf-e81e-43c6-9cd9-0e29fa0f00ae,,T2C,Tumor Free,27.28737219,0:CENSORED,No,White,No,-18.0,PRAD,No,Yes,Roswell Park,G9,0.6,"Prostate Adenocarcinoma, Acinar Type",-34.0
174,268,TCGA-J4-A67S,TCGA-J4-A67S-01,63,1.0,,833.0,-23332.0,0.0,23.27645724,1,0,0.0754,No,8140/3,Yes,0.3055,0.04,18.0,Yes,27.38600125,0:LIVING,9FE9CBAE-37B9-4030-A204-4502760F5DAB,N0,T3A,With Tumor,23.27645724,1:PROGRESSION,No,,No,,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.6,"Prostate Adenocarcinoma, Acinar Type",
175,265,TCGA-J4-A67O,TCGA-J4-A67O-01,59,1.0,,839.0,-21714.0,0.0,27.58325936,0,0,0.0001,No,8140/3,Yes,0.3032,0.01,14.0,No,27.58325936,0:LIVING,3FC9E3B4-8BC5-4BF8-BFF6-DD90346B83A1,N0,T2C,Tumor Free,27.58325936,0:CENSORED,No,,No,,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.466666667,"Prostate Adenocarcinoma, Acinar Type",
176,88,TCGA-EJ-7328,TCGA-EJ-7328-01,70,0.0,-35.0,842.0,-25756.0,0.0,27.68188842,0,1,0.036,No,8550/3,Yes,0.3458,0.0,24.0,No,27.68188842,0:LIVING,42b7d14f-09e5-4d91-bb98-5fe35907a6a9,N0,T3A,Tumor Free,27.68188842,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.733333333,"Prostate Adenocarcinoma, Acinar Type",-50.0
178,228,TCGA-HC-8258,TCGA-HC-8258-01,56,,-29.0,847.0,-20703.0,0.0,27.84627018,0,0,0.0,No,8550/3,Yes,0.2544,1.57,18.0,No,27.84627018,0:LIVING,da5b0169-e4f4-4674-b348-220af03ff4b5,N0,T2C,Tumor Free,27.84627018,0:CENSORED,No,,No,-16.0,PRAD,Yes,No,International Genomics Consortium,HC,0.633333333,"Prostate Adenocarcinoma, Acinar Type",-30.0
180,182,TCGA-G9-7519,TCGA-G9-7519-01,58,1.0,-15.0,849.0,-21276.0,0.0,27.91202288,0,0,0.0001,No,8550/3,Yes,0.3314,0.0,33.0,No,27.91202288,0:LIVING,0f01ec33-00a8-4188-a8f0-e90d46ad9bc7,,T2C,Tumor Free,27.91202288,0:CENSORED,No,,No,-20.0,PRAD,No,Yes,Roswell Park,G9,1.1,"Prostate Adenocarcinoma, Acinar Type",-18.0
181,97,TCGA-EJ-7788,TCGA-EJ-7788-01,53,0.0,-37.0,859.0,-19623.0,0.0,28.2407864,0,1,0.0647,No,8550/3,Yes,0.3475,0.0,27.0,No,28.2407864,0:LIVING,e35336e1-e358-493f-9beb-276b5fc6685a,N0,T3B,Tumor Free,28.2407864,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.9,"Prostate Adenocarcinoma, Acinar Type",-46.0
182,226,TCGA-HC-8256,TCGA-HC-8256-01,53,2.0,-35.0,860.0,-19598.0,0.0,28.27366275,0,0,0.0635,No,8550/3,Yes,0.3097,0.0,21.0,No,28.27366275,0:LIVING,89a297be-ebb5-4b9f-8eda-0e548d14ad91,,T2C,Tumor Free,28.27366275,0:CENSORED,No,,No,-20.0,PRAD,Yes,No,International Genomics Consortium,HC,0.733333333,"Prostate Adenocarcinoma, Acinar Type",-40.0
184,139,TCGA-FC-7708,TCGA-FC-7708-01,52,1.0,-27.0,864.0,-19144.0,0.0,28.40516816,0,1,0.0483,No,8550/3,Yes,0.3334,0.0,26.0,No,28.40516816,0:LIVING,208a75b3-407c-4c5a-8938-3691547b6887,N0,T3A,Tumor Free,28.40516816,0:CENSORED,No,Asian,No,-20.0,PRAD,Yes,No,Asterand,FC,0.866666667,"Prostate Adenocarcinoma, Acinar Type",-36.0
185,199,TCGA-HC-7210,TCGA-HC-7210-01,74,0.0,-21.0,868.0,-27343.0,0.0,28.53667357,0,1,0.0743,No,8550/3,Yes,0.3196,0.0,28.0,No,28.53667357,0:LIVING,6a5af80e-07ad-4cd3-aaab-5db1090835d9,N0,T2A,Tumor Free,28.53667357,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,International Genomics Consortium,HC,0.933333333,"Prostate Adenocarcinoma, Acinar Type",-26.0
186,201,TCGA-HC-7212,TCGA-HC-7212-01,56,0.0,-33.0,870.0,-20576.0,0.0,28.60242628,0,1,0.0854,No,8550/3,Yes,0.3495,0.0,31.0,Yes,28.60242628,0:LIVING,907b64d6-a26a-4092-a247-ac9af444d1c7,N0,T2A,,28.60242628,0:CENSORED,No,White,,-22.0,PRAD,Yes,No,International Genomics Consortium,HC,1.033333333,"Prostate Adenocarcinoma, Acinar Type",-42.0
187,124,TCGA-EJ-A6RC,TCGA-EJ-A6RC-01,64,0.0,-31.0,873.0,-23598.0,0.0,28.70105533,0,0,0.0002,No,8140/3,Yes,0.331,0.0,21.0,No,28.70105533,0:LIVING,AAE0FCA8-99E9-4FDE-A2E9-B0EA500737F8,N0,,Tumor Free,28.70105533,0:CENSORED,Yes,,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.7,"Prostate Adenocarcinoma, Acinar Type",-38.0
188,389,TCGA-V1-A9Z7,TCGA-V1-A9Z7-01,54,4.0,,874.0,-20075.0,,28.73393168,0,0,0.1225,No,8140/3,Yes,0.3332,0.0,25.0,,28.73393168,0:LIVING,4DB62B98-ABD4-4A7C-9FCE-8BBDA2AEC8A3,N0,T3B,,28.73393168,0:CENSORED,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.833333333,"Prostate Adenocarcinoma, Acinar Type",
189,454,TCGA-YL-A8SH,TCGA-YL-A8SH-01,69,0.0,-29.0,,-25395.0,0.0,28.76680804,0,0,0.0699,No,8140/3,Yes,0.3319,0.0,32.0,No,28.76680804,1:DECEASED,BFB973EB-D42D-4900-A606-A381D2317555,N0,T3A,Tumor Free,28.76680804,0:CENSORED,No,,No,-24.0,PRAD,No,Yes,PROCURE Biobank,YL,1.066666667,"Prostate Adenocarcinoma, Acinar Type",-32.0
190,141,TCGA-FC-A4JI,TCGA-FC-A4JI-01,70,16.0,11.0,877.0,-25931.0,0.0,28.83256074,0,0,0.4645,No,8140/3,Yes,0.3483,0.02,26.0,No,28.83256074,0:LIVING,30F623A3-DAE7-41DA-AB10-8786D094209E,,T3A,Tumor Free,28.83256074,0:CENSORED,No,,Yes,12.0,PRAD,Yes,No,Asterand,FC,0.866666667,"Prostate Adenocarcinoma, Acinar Type",2.0
191,42,TCGA-CH-5794,TCGA-CH-5794-01,65,0.0,-33.0,882.0,-23924.0,0.0,28.9969425,0,1,0.044,No,8550/3,Yes,0.2695,0.0,24.0,No,28.9969425,0:LIVING,a80d3ee7-60dd-49bb-b049-9335afc035f5,N0,T2B,Tumor Free,28.9969425,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,Indivumed,CH,0.8,"Prostate Adenocarcinoma, Acinar Type",-28.0
192,327,TCGA-KK-A7B3,TCGA-KK-A7B3-01,62,1.0,-21.0,899.0,-22830.0,0.0,9.6656475,1,0,0.0843,No,8140/3,Yes,0.3256,0.01,29.0,Yes,29.55584048,0:LIVING,AAEB1D59-D6CE-4422-9639-F1E83C002D84,N0,T3B,Tumor Free,9.6656475,1:PROGRESSION,Yes,,No,-18.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,0.933333333,"Prostate Adenocarcinoma, Acinar Type",-14.0
194,267,TCGA-J4-A67R,TCGA-J4-A67R-01,65,0.0,,910.0,-23807.0,0.0,29.91748036,0,0,0.0,No,8140/3,Yes,0.3073,0.05,14.0,No,29.91748036,0:LIVING,DB2779F6-8FE2-48C3-988B-81DB1815A678,N0,T2C,Tumor Free,29.91748036,0:CENSORED,No,,No,,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.466666667,"Prostate Adenocarcinoma, Acinar Type",
195,373,TCGA-V1-A8WN,TCGA-V1-A8WN-01,47,0.0,-39.0,924.0,-17520.0,,30.37774929,0,0,0.0118,No,8140/3,Yes,0.332,0.0,12.0,No,30.37774929,0:LIVING,DC16F348-A49F-4958-A3FF-BC40E18DF2BD,,T2C,,30.37774929,0:CENSORED,No,,No,-20.0,PRAD,No,Yes,University of California San Francisco,V1,0.333333333,"Prostate Adenocarcinoma, Acinar Type",-42.0
196,219,TCGA-HC-7817,TCGA-HC-7817-01,52,0.0,,928.0,-19207.0,0.0,30.50925469,0,0,0.0016,No,8140/3,No,0.3051,0.0,17.0,No,30.50925469,0:LIVING,f3aa40b9-7b4d-465a-b7c9-591aebdb56c2,,T3B,Tumor Free,30.50925469,0:CENSORED,No,,Yes,,,Yes,No,International Genomics Consortium,HC,0.566666667,"Prostate Adenocarcinoma, Acinar Type",
197,433,TCGA-XK-AAJA,TCGA-XK-AAJA-01,62,0.0,,930.0,-22771.0,0.0,30.5750074,0,0,0.1428,No,8140/3,Yes,0.3349,0.05,40.0,No,30.5750074,0:LIVING,D17B1955-0565-46C1-A5A7-ECD41AC0286A,N0,T3A,,30.5750074,0:CENSORED,No,,No,,PRAD,No,Yes,Mayo Clinic Arizona,XK,1.333333333,"Prostate Adenocarcinoma, Acinar Type",
200,220,TCGA-HC-7818,TCGA-HC-7818-01,66,,-31.0,938.0,-24391.0,0.0,30.83801821,0,1,0.0,No,8550/3,Yes,0.3309,0.0,24.0,No,30.83801821,0:LIVING,ebe711e4-45af-4082-bdf6-b0f7ac899b3e,N0,T2C,Tumor Free,30.83801821,0:CENSORED,No,White,No,-22.0,PRAD,Yes,No,International Genomics Consortium,HC,0.8,"Prostate Adenocarcinoma, Acinar Type",-40.0
202,204,TCGA-HC-7231,TCGA-HC-7231-01,66,0.0,-37.0,939.0,-24278.0,0.0,30.87089457,0,0,0.047,No,8550/3,Yes,0.3442,0.0,33.0,No,30.87089457,0:LIVING,b182bda9-3d9f-4958-96eb-bd6cc441830c,,T2C,Tumor Free,30.87089457,0:CENSORED,No,White,No,-14.0,PRAD,Yes,No,International Genomics Consortium,HC,1.1,"Prostate Adenocarcinoma, Acinar Type",-46.0
203,190,TCGA-H9-A6BX,TCGA-H9-A6BX-01,60,0.0,,941.0,-22039.0,0.0,30.93664727,0,0,0.0,No,8140/3,Yes,0.3129,0.0,5.0,No,30.93664727,0:LIVING,3BA3D23D-67E2-4F38-9951-F5CFA1131F9F,,T2C,Tumor Free,30.93664727,0:CENSORED,No,,No,,PRAD,Yes,No,ABS - IUPUI,H9,0.166666667,"Prostate Adenocarcinoma, Acinar Type",
204,263,TCGA-J4-A67M,TCGA-J4-A67M-01,55,1.0,,941.0,-20211.0,0.0,30.93664727,0,0,0.106,No,8140/3,Yes,0.3138,0.03,27.0,No,30.93664727,0:LIVING,67CD72E2-A4CF-48E4-943E-406C252F056A,N0,T3A,Tumor Free,30.93664727,0:CENSORED,No,,No,,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.933333333,"Prostate Adenocarcinoma, Acinar Type",
206,223,TCGA-HC-7821,TCGA-HC-7821-01,54,4.0,-31.0,956.0,-19894.0,0.0,31.42979255,0,1,0.1347,No,8550/3,Yes,0.3378,0.03,21.0,Yes,31.42979255,0:LIVING,929837f9-297a-47c0-ac9a-a142eef620d3,N1,T3B,With Tumor,31.42979255,0:CENSORED,Yes,White,Yes,-22.0,PRAD,Yes,No,International Genomics Consortium,HC,0.766666667,"Prostate Adenocarcinoma, Acinar Type",-34.0
207,171,TCGA-G9-6377,TCGA-G9-6377-01,61,3.0,-11.0,958.0,-22419.0,0.0,31.49554525,0,1,0.1123,No,8550/3,Yes,0.2984,0.0,47.0,No,31.49554525,0:LIVING,007f9081-5093-4323-b4f8-cd510bf20705,N0,T2C,Tumor Free,31.49554525,0:CENSORED,No,White,No,-24.0,PRAD,No,Yes,Roswell Park,G9,1.6,"Prostate Adenocarcinoma, Acinar Type",-10.0
209,333,TCGA-KK-A8I8,TCGA-KK-A8I8-01,69,2.0,-21.0,967.0,-25546.0,0.0,31.79143242,0,0,0.1017,No,8140/3,Yes,0.3249,0.0,16.0,No,31.79143242,0:LIVING,30FA311B-05A2-43E4-9EDC-02B327898132,N0,T3B,Tumor Free,31.79143242,0:CENSORED,No,,Yes,-16.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,0.533333333,"Prostate Adenocarcinoma, Acinar Type",-24.0
210,430,TCGA-XK-AAIR,TCGA-XK-AAIR-01,75,2.0,,972.0,-27703.0,0.0,31.95581418,0,0,0.0691,No,8140/3,Yes,0.3372,0.0,25.0,No,31.95581418,0:LIVING,12D2B93E-A033-4B36-AE81-C15879EB40BD,N0,T2C,Tumor Free,31.95581418,0:CENSORED,No,,No,,PRAD,No,Yes,Mayo Clinic Arizona,XK,0.833333333,"Prostate Adenocarcinoma, Acinar Type",
212,103,TCGA-EJ-7797,TCGA-EJ-7797-01,53,1.0,-33.0,983.0,-19616.0,0.0,32.31745406,0,1,0.015,No,8550/3,Yes,0.3237,0.0,24.0,No,32.31745406,0:LIVING,f98366df-9616-41c0-a6b8-ec92dca7177a,N0,T2C,Tumor Free,32.31745406,0:CENSORED,No,White,No,-18.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.833333333,"Prostate Adenocarcinoma, Acinar Type",-44.0
214,458,TCGA-YL-A8SL,TCGA-YL-A8SL-01,74,13.0,-15.0,987.0,-27033.0,0.0,32.44895946,0,0,0.2142,No,8140/3,Yes,0.3229,0.0,39.0,No,32.44895946,0:LIVING,23EBC73D-BE3B-42F8-9390-BF18A21AFC5C,N1,T3B,Tumor Free,32.44895946,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,PROCURE Biobank,YL,1.3,"Prostate Adenocarcinoma, Acinar Type",-12.0
216,278,TCGA-J4-A83N,TCGA-J4-A83N-01,57,1.0,-21.0,992.0,-20841.0,0.0,32.61334122,0,0,0.0351,No,8140/3,Yes,0.3325,0.0,15.0,Yes,32.61334122,0:LIVING,C024C4B6-0143-4071-9175-7435F1EAAC58,,T2C,Tumor Free,14.23546043,1:PROGRESSION,No,,No,-20.0,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.5,"Prostate Adenocarcinoma, Acinar Type",-22.0
217,186,TCGA-G9-7525,TCGA-G9-7525-01,64,1.0,,994.0,-23481.0,0.0,32.67909393,0,0,0.0583,No,8550/3,Yes,0.3311,0.0,33.0,No,32.67909393,0:LIVING,f4e17ba1-f14f-480e-8fe3-415909fc320a,N0,T2C,Tumor Free,32.67909393,0:CENSORED,No,,No,,PRAD,No,Yes,Roswell Park,G9,1.066666667,"Prostate Adenocarcinoma, Acinar Type",
218,334,TCGA-KK-A8I9,TCGA-KK-A8I9-01,61,0.0,-13.0,1001.0,-22295.0,0.0,30.90377092,1,0,0.0643,No,8140/3,Yes,0.3312,0.0,37.0,Yes,32.90922839,0:LIVING,261C3D74-706E-4751-BD15-8F3C1A402FF0,N0,T3A,Tumor Free,30.90377092,1:PROGRESSION,No,,Yes,-26.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,1.2,"Prostate Adenocarcinoma, Acinar Type",0.0
219,203,TCGA-HC-7230,TCGA-HC-7230-01,50,2.0,-29.0,1001.0,-18577.0,0.0,32.90922839,0,1,0.0527,No,8550/3,Yes,0.3156,0.07,23.0,No,32.90922839,0:LIVING,03c66cf8-bc68-4ee1-a322-689a29b72262,N0,T2C,Tumor Free,32.90922839,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,International Genomics Consortium,HC,0.766666667,"Prostate Adenocarcinoma, Acinar Type",-20.0
220,261,TCGA-J4-A67K,TCGA-J4-A67K-01,68,0.0,,1004.0,-24908.0,0.0,33.00785745,0,0,0.0084,No,8140/3,Yes,0.2956,0.05,26.0,No,33.00785745,0:LIVING,C4C1B5BE-A0E7-4968-92DE-7F34C71207FB,,T2C,Tumor Free,33.00785745,0:CENSORED,No,,No,,PRAD,Yes,No,ABS - Lahey Clinic,J4,0.866666667,"Prostate Adenocarcinoma, Acinar Type",
221,40,TCGA-CH-5791,TCGA-CH-5791-01,72,1.0,-31.0,1004.0,-26390.0,0.0,33.00785745,0,1,0.1138,No,8550/3,Yes,0.2627,0.01,36.0,Yes,33.00785745,0:LIVING,829bed0c-c40d-44fd-aee8-6c7589db60f9,N0,T3A,,13.01903541,1:PROGRESSION,Yes,White,No,-16.0,PRAD,Yes,No,Indivumed,CH,1.2,"Prostate Adenocarcinoma, Acinar Type",-46.0
222,82,TCGA-EJ-7315,TCGA-EJ-7315-01,68,1.0,-23.0,1008.0,-25154.0,0.0,33.13936286,0,1,0.091,No,8550/3,Yes,0.3382,0.0,23.0,No,33.13936286,0:LIVING,2c7ec330-261e-49c7-9424-6d83641dba6d,N0,T3A,Tumor Free,33.13936286,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.433333333,"Prostate Adenocarcinoma, Acinar Type",-32.0
225,325,TCGA-KK-A7B1,TCGA-KK-A7B1-01,65,0.0,-27.0,1063.0,-23803.0,0.0,34.94756222,0,0,0.0261,No,8140/3,Yes,0.3404,0.0,18.0,,34.94756222,0:LIVING,7315BB0A-96A1-45AB-A704-B084D237CF5C,N0,T3A,,34.94756222,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,0.633333333,"Prostate Adenocarcinoma, Acinar Type",-22.0
226,388,TCGA-V1-A9OY,TCGA-V1-A9OY-01,57,0.0,,1067.0,-21170.0,,35.07906763,0,0,0.0229,No,8140/3,Yes,0.3267,0.0,16.0,No,35.07906763,0:LIVING,69FC0351-6496-46B5-BE22-25B80C1DC4CC,N1,T3A,,35.07906763,0:CENSORED,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.533333333,"Prostate Adenocarcinoma, Acinar Type",
227,86,TCGA-EJ-7325,TCGA-EJ-7325-01,63,1.0,,1070.0,-23029.0,0.0,35.17769668,0,0,0.0457,No,8550/3,Yes,0.3188,0.05,18.0,No,35.17769668,0:LIVING,45a04209-8fac-4181-bba3-1437c8fd7f09,N0,T3B,Tumor Free,35.17769668,0:CENSORED,Yes,,No,,PRAD,Yes,No,University of Pittsburgh,EJ,0.6,"Prostate Adenocarcinoma, Acinar Type",
228,91,TCGA-EJ-7781,TCGA-EJ-7781-01,65,1.0,-33.0,1073.0,-23937.0,0.0,35.27632574,0,1,0.064,No,8550/3,Yes,0.3098,0.0,54.0,No,35.27632574,0:LIVING,33283111-9a2f-4d5e-92a5-3435846404f7,N0,T2C,Tumor Free,35.27632574,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,3.6,"Prostate Adenocarcinoma, Acinar Type",-34.0
229,184,TCGA-G9-7522,TCGA-G9-7522-01,49,0.0,-21.0,1078.0,-18033.0,0.0,35.4407075,0,0,0.0051,No,8550/3,Yes,0.3325,0.0,8.0,No,35.4407075,0:LIVING,87959988-bb25-47ee-afc1-9af92592bbe7,N0,T2C,Tumor Free,35.4407075,0:CENSORED,No,,No,-20.0,PRAD,No,Yes,Roswell Park,G9,0.266666667,"Prostate Adenocarcinoma, Acinar Type",-42.0
230,376,TCGA-V1-A8WW,TCGA-V1-A8WW-01,59,2.0,-3.0,1078.0,-21900.0,,35.4407075,0,0,0.2146,No,8140/3,Yes,0.3368,0.0,32.0,Yes,35.4407075,0:LIVING,D843996C-0F17-4482-8466-9F6144981B8A,N1,T3B,,35.4407075,0:CENSORED,No,,No,-6.0,PRAD,No,Yes,University of California San Francisco,V1,1.066666667,"Prostate Adenocarcinoma, Acinar Type",-6.0
231,208,TCGA-HC-7737,TCGA-HC-7737-01,55,1.0,-25.0,1090.0,-20122.0,0.0,35.83522372,0,0,0.0001,No,8550/3,Yes,0.326,0.09,18.0,No,35.83522372,0:LIVING,73f875cb-bcfc-43ba-ab97-4e94caf836d4,N1,T2C,Tumor Free,35.83522372,0:CENSORED,No,Black or African American,No,-22.0,PRAD,No,Yes,International Genomics Consortium,HC,0.6,"Prostate Adenocarcinoma, Acinar Type",-38.0
233,207,TCGA-HC-7736,TCGA-HC-7736-01,59,1.0,-31.0,1103.0,-21703.0,0.0,36.2626163,0,1,0.1245,No,8550/3,Yes,0.3035,0.0,19.0,No,36.2626163,0:LIVING,922e5166-85f5-4365-9c09-f8bdc1722da6,N0,T2C,Tumor Free,36.2626163,0:CENSORED,No,White,No,-18.0,PRAD,No,Yes,International Genomics Consortium,HC,0.666666667,"Prostate Adenocarcinoma, Acinar Type",-34.0
234,98,TCGA-EJ-7789,TCGA-EJ-7789-01,66,7.0,-13.0,1105.0,-24107.0,0.0,36.328369,0,1,0.3433,No,8550/3,Yes,0.3603,0.06,30.0,No,36.328369,0:LIVING,1f4ff2c7-3fbb-46a1-99cf-68d2c33c5175,N0,T3A,Tumor Free,36.328369,0:CENSORED,No,Black or African American,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.866666667,"Prostate Adenocarcinoma, Acinar Type",-20.0
235,196,TCGA-HC-7080,TCGA-HC-7080-01,66,0.0,-27.0,1106.0,-24243.0,0.0,36.36124536,0,1,0.1135,No,8550/3,Yes,0.2875,0.05,32.0,Yes,36.36124536,0:LIVING,fd50ff41-ec9d-4db1-a673-36ba0ca1eac8,N0,T2A,Tumor Free,29.39145872,1:PROGRESSION,No,White,No,-20.0,PRAD,No,Yes,International Genomics Consortium,HC,1.066666667,"Prostate Adenocarcinoma, Acinar Type",-30.0
238,99,TCGA-EJ-7791,TCGA-EJ-7791-01,67,,-31.0,1118.0,-24621.0,0.0,36.75576158,0,1,0.0001,No,8550/3,Yes,0.3074,0.0,19.0,No,36.75576158,0:LIVING,4fe004e5-49f9-4336-a690-6ebad512c813,N0,T2C,Tumor Free,36.75576158,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.633333333,"Prostate Adenocarcinoma, Acinar Type",-38.0
239,435,TCGA-XK-AAJR,TCGA-XK-AAJR-01,61,2.0,,1124.0,-22643.0,0.0,4.306802117,1,0,0.0989,No,8140/3,Yes,0.3205,0.0,24.0,No,36.95301969,0:LIVING,A3A4A518-2DAC-4846-9476-1AA7E0C1FB5E,N0,T3A,Tumor Free,4.306802117,1:PROGRESSION,No,,No,,PRAD,No,Yes,Mayo Clinic Arizona,XK,0.8,"Prostate Adenocarcinoma, Acinar Type",
242,81,TCGA-EJ-7314,TCGA-EJ-7314-01,62,1.0,-33.0,1150.0,-22766.0,0.0,37.80780485,0,1,0.0268,No,8550/3,Yes,0.3115,0.0,33.0,No,37.80780485,0:LIVING,88c87cce-4361-499c-9e3a-e9d9040af2db,N0,T3B,Tumor Free,37.80780485,0:CENSORED,No,White,No,-18.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.933333333,"Prostate Adenocarcinoma, Acinar Type",-42.0
244,172,TCGA-G9-6378,TCGA-G9-6378-01,54,2.0,-25.0,1155.0,-19879.0,0.0,37.97218661,0,1,0.0009,No,8550/3,Yes,0.2901,0.0,22.0,No,37.97218661,0:LIVING,12f225d0-cbff-44eb-9183-bacc7f33b090,,T2C,Tumor Free,37.97218661,0:CENSORED,No,Black or African American,No,-22.0,PRAD,No,Yes,Roswell Park,G9,0.733333333,"Prostate Adenocarcinoma, Acinar Type",-38.0
245,205,TCGA-HC-7232,TCGA-HC-7232-01,66,2.0,-31.0,1161.0,-24324.0,0.0,25.18328566,1,1,0.1165,No,8550/3,Yes,0.3381,0.0,23.0,Yes,38.16944472,0:LIVING,ce3585d3-7388-4d05-84c8-64e0883003b3,,T3B,Tumor Free,25.18328566,1:PROGRESSION,No,White,No,-20.0,PRAD,Yes,No,International Genomics Consortium,HC,0.766666667,"Prostate Adenocarcinoma, Acinar Type",-38.0
246,92,TCGA-EJ-7782,TCGA-EJ-7782-01,71,2.0,-31.0,1167.0,-25965.0,0.0,38.36670283,0,1,0.1234,No,8550/3,Yes,0.4712,4.18,357.0,No,38.36670283,0:LIVING,1426b4bf-f4a5-477c-bbbb-e0e656549764,N0,T2C,Tumor Free,38.36670283,0:CENSORED,No,Black or African American,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,21.43333333,"Prostate Adenocarcinoma, Acinar Type",-30.0
247,50,TCGA-EJ-5502,TCGA-EJ-5502-01,50,0.0,-37.0,1171.0,-18447.0,0.0,38.49820824,0,0,0.0,No,8550/3,Yes,0.2697,0.0,11.0,No,38.49820824,0:LIVING,48e83a4c-c602-494a-80cd-e2f4b4dd701e,N0,T2C,Tumor Free,38.49820824,0:CENSORED,No,,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.366666667,"Prostate Adenocarcinoma, Acinar Type",-34.0
248,95,TCGA-EJ-7785,TCGA-EJ-7785-01,54,0.0,-37.0,1177.0,-19939.0,0.0,38.69546635,0,1,0.0206,No,8550/3,Yes,0.3321,0.0,18.0,No,38.69546635,0:LIVING,2def2a53-d2e8-46f0-8b07-f32dbf1833a4,N0,T3A,Tumor Free,38.69546635,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.2,"Prostate Adenocarcinoma, Acinar Type",-32.0
250,382,TCGA-V1-A9OF,TCGA-V1-A9OF-01,49,0.0,,1184.0,-18250.0,,38.92560082,0,0,0.0223,No,8140/3,Yes,0.3231,0.04,13.0,No,38.92560082,0:LIVING,D4DC7C5C-45B3-4741-B0C1-FEE477DA2EF4,,T2C,,38.92560082,0:CENSORED,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.433333333,"Prostate Adenocarcinoma, Acinar Type",
251,181,TCGA-G9-7510,TCGA-G9-7510-01,66,4.0,-17.0,1185.0,-24187.0,0.0,38.95847717,0,0,0.0311,No,8550/3,Yes,0.3182,0.0,34.0,No,38.95847717,0:LIVING,f211f7a9-cf3b-432c-9ea0-1172cce14e9d,N0,T3A,Tumor Free,38.95847717,0:CENSORED,No,,No,-18.0,PRAD,No,Yes,Roswell Park,G9,1.133333333,"Prostate Adenocarcinoma, Acinar Type",-26.0
252,370,TCGA-V1-A8MM,TCGA-V1-A8MM-01,60,1.0,,1195.0,-22265.0,,32.54758852,1,0,0.1216,No,8140/3,Yes,0.3341,0.0,17.0,Yes,39.28724069,0:LIVING,94D6675E-27AE-4F34-9D53-6E19238EB01D,N0,T3A,,32.54758852,1:PROGRESSION,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.566666667,"Prostate Adenocarcinoma, Acinar Type",
253,163,TCGA-G9-6364,TCGA-G9-6364-01,72,2.0,-27.0,1198.0,-26603.0,0.0,39.38586974,0,1,0.0368,No,8550/3,Yes,0.2914,0.0,21.0,No,39.38586974,0:LIVING,f8d8b417-5945-42a5-850a-fbc04b4f0e61,N0,T3A,Tumor Free,39.38586974,0:CENSORED,Yes,White,No,-20.0,PRAD,No,Yes,Roswell Park,G9,1.4,"Prostate Adenocarcinoma, Acinar Type",-46.0
254,167,TCGA-G9-6369,TCGA-G9-6369-01,55,1.0,,1215.0,-20238.0,0.0,39.94476773,0,1,0.0878,No,8550/3,Yes,0.2823,0.0,31.0,No,39.94476773,0:LIVING,e0ff90e5-e6c3-4fb5-9512-6f09a891378b,N0,T2C,Tumor Free,39.94476773,0:CENSORED,No,White,No,,PRAD,No,Yes,Roswell Park,G9,1.033333333,"Prostate Adenocarcinoma, Acinar Type",
256,200,TCGA-HC-7211,TCGA-HC-7211-01,62,2.0,-33.0,1221.0,-22768.0,0.0,40.14202584,0,1,0.0483,No,8550/3,Yes,0.3293,0.6,21.0,No,40.14202584,0:LIVING,ec3870c9-4930-4af7-b2eb-1e16c9ec9f14,N0,T2C,Tumor Free,40.14202584,0:CENSORED,No,White,No,-22.0,PRAD,No,Yes,International Genomics Consortium,HC,0.7,"Prostate Adenocarcinoma, Acinar Type",-28.0
258,169,TCGA-G9-6371,TCGA-G9-6371-01,58,3.0,-27.0,1226.0,-21365.0,0.0,40.3064076,0,1,0.0138,No,8550/3,Yes,0.3089,0.0,27.0,No,40.3064076,0:LIVING,d5c43a14-21ab-4178-ae33-2d8b7baa256f,,T2C,Tumor Free,40.3064076,0:CENSORED,No,White,No,-20.0,PRAD,No,Yes,Roswell Park,G9,0.933333333,"Prostate Adenocarcinoma, Acinar Type",-26.0
259,289,TCGA-J9-A8CN,TCGA-J9-A8CN-01,53,1.0,-17.0,1237.0,-19662.0,0.0,40.66804747,0,0,0.0641,No,8140/3,Yes,0.3236,0.0,19.0,No,40.66804747,0:LIVING,186D7F36-4E93-4AB2-BC23-95D5CD296656,,T3A,Tumor Free,40.66804747,0:CENSORED,Yes,,No,-18.0,PRAD,Yes,No,Melbourne Health,J9,0.633333333,"Prostate Adenocarcinoma, Acinar Type",-20.0
260,357,TCGA-QU-A6IM,TCGA-QU-A6IM-01,59,1.0,,1247.0,-21792.0,0.0,40.99681099,0,0,0.0852,No,8140/3,Yes,0.3139,0.03,62.0,No,40.99681099,0:LIVING,D1B31524-8034-4FCE-B14E-1CEF33C26CA5,N0,T2A,,40.99681099,0:CENSORED,Yes,,No,,PRAD,No,Yes,Harvard Beth Israel,QU,2.033333333,"Prostate Adenocarcinoma, Acinar Type",
261,402,TCGA-VN-A88P,TCGA-VN-A88P-01,60,2.0,-15.0,1260.0,-21916.0,0.0,41.42420357,0,0,0.1159,No,8140/3,Yes,0.3267,0.0,34.0,No,41.42420357,0:LIVING,74C7DD37-7FF5-47AC-AEB7-14202871B6F1,N0,T2C,Tumor Free,41.42420357,0:CENSORED,No,,No,-24.0,PRAD,No,Yes,NCI Urologic Oncology Branch,VN,1.133333333,"Prostate Adenocarcinoma, Acinar Type",-22.0
263,146,TCGA-G9-6329,TCGA-G9-6329-01,67,4.0,-23.0,1266.0,-24797.0,0.0,41.62146168,0,1,0.0115,No,8550/3,Yes,0.2856,0.0,24.0,No,41.62146168,0:LIVING,a08fd0a6-a89a-4adb-b641-d4c1238abb71,,T2C,Tumor Free,41.62146168,0:CENSORED,No,White,No,-20.0,PRAD,No,Yes,Roswell Park,G9,0.833333333,"Prostate Adenocarcinoma, Acinar Type",-18.0
264,8,TCGA-2A-AAYO,TCGA-2A-AAYO-01,57,1.0,,1272.0,-21183.0,0.0,41.8187198,0,0,0.0208,No,8140/3,Yes,0.3296,0.06,20.0,No,41.8187198,0:LIVING,8C0D361F-EAAB-4768-90F2-B7A610E2BBB1,,T2C,Tumor Free,41.8187198,0:CENSORED,No,,No,,PRAD,No,Yes,Memorial Sloan Kettering Cancer Center,2A,0.666666667,"Prostate Adenocarcinoma, Acinar Type",
265,74,TCGA-EJ-5531,TCGA-EJ-5531-01,62,2.0,-37.0,1273.0,-22760.0,0.0,41.85159615,0,1,0.0111,No,8550/3,Yes,0.3296,0.29,29.0,No,41.85159615,0:LIVING,adf3c2f7-d5f9-41c3-bd8c-7f9f1f22ff73,N0,T3A,Tumor Free,41.85159615,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.966666667,"Prostate Adenocarcinoma, Acinar Type",-30.0
267,102,TCGA-EJ-7794,TCGA-EJ-7794-01,67,0.0,-35.0,1306.0,-24478.0,0.0,42.93651576,0,1,0.0372,No,8550/3,Yes,0.3006,0.0,13.0,No,42.93651576,0:LIVING,aeec3005-25d7-45fc-a9ff-014d57960216,N0,T2C,Tumor Free,42.93651576,0:CENSORED,No,White,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.833333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
268,417,TCGA-VP-A87K,TCGA-VP-A87K-01,63,4.0,-21.0,1306.0,-23030.0,0.0,17.52309564,1,0,0.1171,No,8500/3,Yes,0.3178,0.02,29.0,Yes,42.93651576,0:LIVING,24D7D4D8-F5C1-4D71-80E0-72A429FC9DBD,N0,T3B,With Tumor,17.52309564,1:PROGRESSION,No,,No,-22.0,PRAD,No,Yes,Washington University,VP,0.966666667,"Prostate Adenocarcinoma, Other Subtype",-22.0
269,295,TCGA-KC-A4BV,TCGA-KC-A4BV-01,66,2.0,-37.0,1328.0,-24138.0,0.0,43.65979551,1,0,0.1314,No,8140/3,Yes,0.3105,0.0,34.0,Yes,43.65979551,0:LIVING,A8C954B7-3077-4FF1-B311-D4B4BFA49786,N0,T3A,With Tumor,43.65979551,1:PROGRESSION,No,,No,-24.0,PRAD,No,Yes,Cornell Medical College,KC,1.133333333,"Prostate Adenocarcinoma, Acinar Type",-52.0
272,206,TCGA-HC-7233,TCGA-HC-7233-01,73,0.0,-31.0,1355.0,,0.0,44.54745701,0,0,0.0009,No,8550/3,Yes,0.3436,0.05,29.0,No,44.54745701,0:LIVING,e2b33861-2247-413f-b2e5-9be3b604666c,N0,T2A,With Tumor,44.54745701,0:CENSORED,Yes,White,No,-20.0,PRAD,No,Yes,International Genomics Consortium,HC,0.966666667,"Prostate Adenocarcinoma, Acinar Type",-34.0
273,395,TCGA-V1-A9ZR,TCGA-V1-A9ZR-01,68,0.0,,1361.0,-25185.0,,44.74471513,0,0,0.0727,No,8140/3,Yes,0.3482,0.0,33.0,,44.74471513,0:LIVING,338FE754-FC4A-4294-BA15-42D4C7C9AC10,N0,T4,,44.74471513,0:CENSORED,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,1.133333333,"Prostate Adenocarcinoma, Acinar Type",
274,164,TCGA-G9-6365,TCGA-G9-6365-01,71,0.0,-29.0,1363.0,-26207.0,0.0,44.81046783,0,1,0.0142,No,8550/3,Yes,0.2934,0.0,24.0,No,44.81046783,0:LIVING,6845076e-e940-4437-8618-81db4a447544,N0,T4,Tumor Free,44.81046783,0:CENSORED,No,White,No,-22.0,PRAD,No,Yes,Roswell Park,G9,1.633333333,"Prostate Adenocarcinoma, Acinar Type",-24.0
275,7,TCGA-2A-AAYF,TCGA-2A-AAYF-01,57,0.0,,1364.0,-20866.0,0.0,44.84334418,0,0,0.0222,No,8140/3,Yes,0.3205,0.0,14.0,No,44.84334418,0:LIVING,490E84ED-3C02-4593-990E-ADE5C109DF44,,T3A,Tumor Free,44.84334418,0:CENSORED,No,,No,,PRAD,No,Yes,Memorial Sloan Kettering Cancer Center,2A,0.466666667,"Prostate Adenocarcinoma, Acinar Type",
276,49,TCGA-EJ-5501,TCGA-EJ-5501-01,55,2.0,-23.0,1365.0,-20409.0,0.0,44.87622054,0,1,0.0709,No,8550/3,Yes,0.2751,0.02,17.0,No,44.87622054,0:LIVING,8df0c1e8-966c-4f46-ad15-fae9e745a32e,N0,T3B,Tumor Free,44.87622054,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.566666667,"Prostate Adenocarcinoma, Acinar Type",-24.0
277,418,TCGA-VP-AA1N,TCGA-VP-AA1N-01,70,16.0,,1365.0,-25781.0,0.0,44.87622054,0,0,0.1897,No,8140/3,Yes,0.3318,0.0,30.0,No,44.87622054,0:LIVING,EA953CE5-7082-41FF-8E38-760FE4100414,N0,T3A,Tumor Free,44.87622054,0:CENSORED,No,,Yes,,PRAD,No,Yes,Washington University,VP,1.0,"Prostate Adenocarcinoma, Acinar Type",
278,403,TCGA-VN-A88Q,TCGA-VN-A88Q-01,60,2.0,-31.0,1366.0,-22087.0,0.0,44.90909689,0,0,0.0606,No,8140/3,Yes,0.3317,0.0,30.0,No,44.90909689,0:LIVING,AB540819-9531-4E99-868A-751649F25E6A,N0,T2C,Tumor Free,44.90909689,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,NCI Urologic Oncology Branch,VN,1.066666667,"Prostate Adenocarcinoma, Other Subtype",-36.0
279,162,TCGA-G9-6363,TCGA-G9-6363-01,64,1.0,-13.0,1378.0,-23480.0,0.0,45.30361311,0,1,0.0845,No,8550/3,Yes,0.2953,0.0,44.0,No,45.30361311,0:LIVING,b5b3871c-078c-46a7-ac50-ef916d4a6781,N0,T4,Tumor Free,45.30361311,0:CENSORED,No,White,No,-12.0,PRAD,No,Yes,Roswell Park,G9,2.0,"Prostate Adenocarcinoma, Acinar Type",-12.0
281,54,TCGA-EJ-5506,TCGA-EJ-5506-01,67,,-35.0,1381.0,-24617.0,0.0,45.40224217,0,1,0.0,No,8550/3,Yes,0.2664,0.01,8.0,No,45.40224217,0:LIVING,e5e4d3b6-8e58-4dcf-8f67-a00e656a8e27,N1,T3B,Tumor Free,45.40224217,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.266666667,"Prostate Adenocarcinoma, Acinar Type",-48.0
282,394,TCGA-V1-A9ZK,TCGA-V1-A9ZK-01,68,1.0,,1383.0,-25185.0,,45.46799487,0,0,0.0276,No,8490/3,Yes,0.3281,0.0,22.0,No,45.46799487,0:LIVING,7DC62C0F-B82D-417F-89A7-4CB984A9D304,N0,T3B,,45.46799487,0:CENSORED,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.733333333,"Prostate Adenocarcinoma, Acinar Type",
284,51,TCGA-EJ-5503,TCGA-EJ-5503-01,50,0.0,-37.0,1391.0,-18395.0,0.0,45.73100569,0,1,0.0002,No,8550/3,Yes,0.2653,0.0,7.0,No,45.73100569,0:LIVING,aa252f78-ebf3-42f9-86af-bb6e57345706,N0,T3A,Tumor Free,45.73100569,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.233333333,"Prostate Adenocarcinoma, Acinar Type",-44.0
285,456,TCGA-YL-A8SJ,TCGA-YL-A8SJ-01,60,2.0,-37.0,1395.0,-21916.0,0.0,24.72301673,1,0,0.0629,No,8140/3,Yes,0.3334,0.0,26.0,Yes,45.8625111,0:LIVING,F3EC5BF3-97AE-4033-91A6-084A1AA152A4,N0,T3B,With Tumor,24.72301673,1:PROGRESSION,No,,No,-20.0,PRAD,No,Yes,PROCURE Biobank,YL,0.866666667,"Prostate Adenocarcinoma, Acinar Type",-46.0
286,100,TCGA-EJ-7792,TCGA-EJ-7792-01,53,0.0,-37.0,1396.0,-19454.0,0.0,45.89538745,0,1,0.0252,No,8550/3,Yes,0.3138,0.01,17.0,No,45.89538745,0:LIVING,28689d40-03e5-4e17-aba1-f2d571535eed,N0,T2C,Tumor Free,45.89538745,0:CENSORED,No,White,No,-24.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.133333333,"Prostate Adenocarcinoma, Acinar Type",-46.0
287,48,TCGA-EJ-5499,TCGA-EJ-5499-01,61,1.0,-27.0,1415.0,-22286.0,0.0,46.52003814,0,1,0.0438,No,8550/3,Yes,0.2581,0.0,30.0,No,46.52003814,0:LIVING,fd1aa612-df86-4d48-892d-2acebd76ea96,N0,T3A,Tumor Free,46.52003814,0:CENSORED,No,Asian,No,-14.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.0,"Prostate Adenocarcinoma, Acinar Type",-26.0
288,160,TCGA-G9-6361,TCGA-G9-6361-01,61,1.0,-33.0,1415.0,-22565.0,0.0,46.52003814,0,1,0.0515,No,8550/3,Yes,0.2999,0.0,32.0,No,46.52003814,0:LIVING,71d14304-ccb0-4a4c-b935-8c014ca75fd0,N0,T3A,Tumor Free,46.52003814,0:CENSORED,No,White,No,-22.0,PRAD,No,Yes,Roswell Park,G9,1.066666667,"Prostate Adenocarcinoma, Acinar Type",-28.0
290,159,TCGA-G9-6356,TCGA-G9-6356-01,60,2.0,-37.0,1434.0,-22010.0,0.0,47.14468883,0,1,0.0021,No,8550/3,Yes,0.2889,0.0,23.0,No,47.14468883,0:LIVING,1d7ffbe7-6139-412b-8739-8082a63a2b33,N0,T3B,Tumor Free,47.14468883,0:CENSORED,No,White,No,-22.0,PRAD,No,Yes,Roswell Park,G9,1.566666667,"Prostate Adenocarcinoma, Acinar Type",-42.0
292,365,TCGA-V1-A8MF,TCGA-V1-A8MF-01,65,2.0,-23.0,1449.0,-24090.0,,47.63783411,0,0,0.0886,No,8140/3,Yes,0.3376,0.0,28.0,No,47.63783411,0:LIVING,56DF9DE6-613D-44CE-8827-9213CC6C8B56,N0,T3A,,47.63783411,0:CENSORED,No,,No,-26.0,PRAD,No,Yes,University of California San Francisco,V1,0.966666667,"Prostate Adenocarcinoma, Acinar Type",-12.0
293,55,TCGA-EJ-5507,TCGA-EJ-5507-01,54,4.0,-27.0,1457.0,-19759.0,0.0,47.90084492,0,1,0.1945,No,8550/3,Yes,0.2557,0.05,29.0,No,47.90084492,0:LIVING,607200f5-df80-4f5d-90fb-fdc455a7415b,N1,T3B,Tumor Free,47.90084492,0:CENSORED,No,White,No,-10.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.966666667,"Prostate Adenocarcinoma, Acinar Type",-40.0
294,426,TCGA-XJ-A9DI,TCGA-XJ-A9DI-01,62,0.0,-31.0,1461.0,,0.0,48.03235033,0,0,0.0003,No,8140/3,Yes,0.3393,0.0,17.0,No,48.03235033,0:LIVING,39A5AEBE-ACAD-4141-AA5A-66228C4049F8,N0,T3B,Tumor Free,48.03235033,0:CENSORED,No,,Yes,-22.0,PRAD,No,Yes,University of Kansas,XJ,0.566666667,"Prostate Adenocarcinoma, Acinar Type",-44.0
295,57,TCGA-EJ-5509,TCGA-EJ-5509-01,63,2.0,-29.0,1464.0,-23368.0,0.0,48.13097939,0,1,0.1386,No,8550/3,Yes,0.2652,0.0,19.0,No,48.13097939,0:LIVING,13ce70a8-785c-4b59-b073-41922cb201f9,N0,T2C,Tumor Free,48.13097939,0:CENSORED,No,White,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.633333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
296,59,TCGA-EJ-5511,TCGA-EJ-5511-01,55,3.0,-35.0,1476.0,-20409.0,0.0,48.52549561,0,1,0.1235,No,8550/3,Yes,0.2797,0.02,36.0,No,48.52549561,0:LIVING,f8a42feb-fbc9-4a13-bad5-1dcefca2a9bf,N0,T3A,Tumor Free,48.52549561,0:CENSORED,No,Black or African American,No,-18.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.2,"Prostate Adenocarcinoma, Acinar Type",-40.0
297,43,TCGA-EJ-5494,TCGA-EJ-5494-01,50,0.0,-39.0,1477.0,-18596.0,0.0,48.55837196,0,1,0.0008,No,8550/3,Yes,0.2665,0.0,27.0,No,48.55837196,0:LIVING,e27c50e2-2a41-4f8c-9ef8-2bc51fb0c23e,N0,T3A,Tumor Free,48.55837196,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.9,"Prostate Adenocarcinoma, Acinar Type",-30.0
298,446,TCGA-YL-A8HM,TCGA-YL-A8HM-01,66,7.0,-11.0,1482.0,-24121.0,0.0,48.42686656,1,0,0.2811,No,8140/3,Yes,0.3376,0.02,34.0,Yes,48.72275372,0:LIVING,EFF14FED-8A21-41C5-8ED3-75346A06E44E,N0,T3B,Tumor Free,48.42686656,1:PROGRESSION,No,,Yes,-2.0,PRAD,No,Yes,PROCURE Biobank,YL,1.133333333,"Prostate Adenocarcinoma, Acinar Type",-26.0
299,308,TCGA-KK-A6E0,TCGA-KK-A6E0-01,59,1.0,-9.0,1483.0,-21700.0,0.0,30.93664727,1,0,0.1489,No,8140/3,Yes,0.3138,0.0,20.0,No,48.75563008,0:LIVING,D112136D-34FA-426E-B432-4D1E4286ADF8,N0,T3A,With Tumor,30.93664727,1:PROGRESSION,No,,Yes,-18.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,0.7,"Prostate Adenocarcinoma, Acinar Type",-2.0
300,155,TCGA-G9-6348,TCGA-G9-6348-01,68,1.0,-9.0,1515.0,-24936.0,0.0,49.80767334,0,1,0.082,No,8550/3,Yes,0.2995,0.0,34.0,No,49.80767334,0:LIVING,8ad78c4f-c84c-4f9e-88c9-42a05eb65498,N0,T2C,Tumor Free,49.80767334,0:CENSORED,No,White,No,-22.0,PRAD,No,Yes,Roswell Park,G9,2.266666667,"Prostate Adenocarcinoma, Acinar Type",-4.0
301,392,TCGA-V1-A9ZG,TCGA-V1-A9ZG-01,64,1.0,,1517.0,-23725.0,,49.87342605,0,0,0.0269,No,8140/3,Yes,0.3293,0.0,24.0,No,49.87342605,0:LIVING,DEC99F86-622B-477F-A26A-98C954FB1F17,N0,T2C,,49.87342605,0:CENSORED,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.8,"Prostate Adenocarcinoma, Acinar Type",
304,157,TCGA-G9-6353,TCGA-G9-6353-01,58,0.0,-27.0,1542.0,-21221.0,0.0,50.69533485,0,1,0.0,No,8550/3,Yes,0.2785,0.0,5.0,No,50.69533485,0:LIVING,bcc94953-ce79-428e-99c1-632e42c1b9bc,,T3A,Tumor Free,50.69533485,0:CENSORED,No,White,No,-20.0,PRAD,No,Yes,Roswell Park,G9,0.333333333,"Prostate Adenocarcinoma, Acinar Type",-30.0
305,179,TCGA-G9-6499,TCGA-G9-6499-01,66,20.0,-13.0,1543.0,-24388.0,0.0,50.7282112,0,1,0.2884,No,8550/3,Yes,0.2846,0.04,32.0,No,50.7282112,0:LIVING,acd5ceef-c5cf-4e95-9394-c50fdbc70c8d,N0,T3A,Tumor Free,50.7282112,0:CENSORED,No,White,No,-24.0,PRAD,No,Yes,Roswell Park,G9,2.133333333,"Prostate Adenocarcinoma, Acinar Type",-8.0
307,437,TCGA-XK-AAJU,TCGA-XK-AAJU-01,65,0.0,,1576.0,-23958.0,0.0,51.81313082,0,0,0.0,No,8140/3,Yes,0.3238,0.03,1.0,No,51.81313082,0:LIVING,ED7084F8-060C-4780-8B35-A03A5EAB9684,N0,T2C,Tumor Free,51.81313082,0:CENSORED,No,,No,,PRAD,No,Yes,Mayo Clinic Arizona,XK,0.033333333,"Prostate Adenocarcinoma, Acinar Type",
308,180,TCGA-G9-7509,TCGA-G9-7509-01,48,0.0,,1610.0,-17538.0,0.0,52.93092678,0,0,0.0096,No,8550/3,Yes,0.3225,0.0,20.0,No,52.93092678,0:LIVING,7d0c6960-710f-42c7-889e-c3a7d4a30b3c,,T2C,Tumor Free,52.93092678,0:CENSORED,No,,No,,PRAD,No,Yes,Roswell Park,G9,0.666666667,"Prostate Adenocarcinoma, Acinar Type",
309,318,TCGA-KK-A7AQ,TCGA-KK-A7AQ-01,62,1.0,,1610.0,-22731.0,0.0,40.01052043,1,0,0.1193,No,8140/3,Yes,0.3307,0.0,33.0,No,52.93092678,0:LIVING,CECF4EE9-7610-4F47-A825-7FDE8233B75D,N0,T2C,Tumor Free,40.01052043,1:PROGRESSION,No,,No,,PRAD,No,Yes,MD Anderson Cancer Center,KK,1.1,"Prostate Adenocarcinoma, Acinar Type",
310,443,TCGA-YL-A8HJ,TCGA-YL-A8HJ-01,58,0.0,-33.0,1611.0,-21416.0,0.0,52.96380314,0,0,0.0091,No,8140/3,Yes,0.3259,0.0,30.0,No,52.96380314,0:LIVING,666D8B0C-593F-4EC3-B16A-2DADBEAD8C32,,T3B,Tumor Free,52.96380314,0:CENSORED,No,,Yes,-22.0,PRAD,No,Yes,PROCURE Biobank,YL,1.0,"Prostate Adenocarcinoma, Other Subtype",-40.0
313,412,TCGA-VP-A87C,TCGA-VP-A87C-01,67,3.0,-35.0,1690.0,-24608.0,0.0,55.56103495,0,0,0.0648,No,8140/3,Yes,0.3158,0.0,20.0,No,55.56103495,0:LIVING,7C398299-D789-4185-ADFA-194817877947,N0,T2C,Tumor Free,55.56103495,0:CENSORED,No,,No,-24.0,PRAD,No,Yes,Washington University,VP,0.666666667,"Prostate Adenocarcinoma, Acinar Type",-44.0
314,152,TCGA-G9-6342,TCGA-G9-6342-01,61,1.0,-27.0,1696.0,-22472.0,0.0,55.75829306,0,1,0.0524,No,8550/3,Yes,0.2949,0.0,52.0,No,55.75829306,0:LIVING,00e41e6a-9fe7-44f9-978b-7b05b179506a,,T3A,Tumor Free,55.75829306,0:CENSORED,No,White,No,-20.0,PRAD,No,Yes,Roswell Park,G9,3.1,"Prostate Adenocarcinoma, Acinar Type",-44.0
316,47,TCGA-EJ-5498,TCGA-EJ-5498-01,56,2.0,-39.0,1720.0,-20472.0,0.0,56.54732551,0,1,0.0012,No,8550/3,Yes,0.2612,0.01,28.0,No,56.54732551,0:LIVING,79ec7468-9aaf-4bb0-94c7-72be4f497868,N0,T2C,Tumor Free,56.54732551,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.933333333,"Prostate Adenocarcinoma, Acinar Type",-38.0
317,177,TCGA-G9-6496,TCGA-G9-6496-01,61,1.0,,1726.0,-22602.0,0.0,56.74458362,0,1,0.0874,No,8550/3,Yes,0.2946,0.04,33.0,No,56.74458362,0:LIVING,ce2b7e17-424e-4954-8a68-19d7f98d2e7e,N0,T2C,Tumor Free,56.74458362,0:CENSORED,No,White,No,,PRAD,No,Yes,Roswell Park,G9,2.233333333,"Prostate Adenocarcinoma, Acinar Type",
318,60,TCGA-EJ-5512,TCGA-EJ-5512-01,46,0.0,-29.0,1733.0,-17127.0,0.0,56.97471809,0,1,0.0309,No,8550/3,Yes,0.262,0.0,13.0,No,56.97471809,0:LIVING,c28f931f-5ab2-4899-9fe9-54024f082d92,N0,T2C,Tumor Free,56.97471809,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.466666667,"Prostate Adenocarcinoma, Acinar Type",-42.0
319,44,TCGA-EJ-5495,TCGA-EJ-5495-01,68,4.0,-43.0,1760.0,-24904.0,0.0,57.86237959,0,1,0.0709,No,8550/3,Yes,0.2615,0.0,68.0,No,57.86237959,0:LIVING,962dd3d5-8501-4658-8cb9-2424b476124c,N1,T3B,Tumor Free,57.86237959,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,2.266666667,"Prostate Adenocarcinoma, Acinar Type",-46.0
321,416,TCGA-VP-A87J,TCGA-VP-A87J-01,56,3.0,-23.0,1774.0,-20792.0,0.0,58.32264852,0,0,0.0632,No,8140/3,Yes,0.3196,0.04,28.0,No,58.32264852,0:LIVING,486D225F-ECA6-499B-A142-DD86137B22E4,N1,T3A,With Tumor,58.32264852,0:CENSORED,No,,No,-20.0,PRAD,No,Yes,Washington University,VP,0.933333333,"Prostate Adenocarcinoma, Acinar Type",-26.0
323,173,TCGA-G9-6379,TCGA-G9-6379-01,68,2.0,,1778.0,-25126.0,0.0,58.45415393,0,0,0.0722,No,8550/3,Yes,0.2984,0.01,23.0,No,58.45415393,0:LIVING,d33074f0-5f88-4995-9439-76068a9f4836,N0,T3B,Tumor Free,58.45415393,0:CENSORED,No,,No,,PRAD,No,Yes,Roswell Park,G9,0.766666667,"Prostate Adenocarcinoma, Acinar Type",
324,72,TCGA-EJ-5527,TCGA-EJ-5527-01,69,2.0,-33.0,1778.0,-25234.0,0.0,58.45415393,0,1,0.0694,No,8550/3,Yes,0.2574,0.0,29.0,No,58.45415393,0:LIVING,ba0c9096-5f35-4f0a-ae98-ee1a695b55f0,N0,T3A,Tumor Free,58.45415393,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.966666667,"Prostate Adenocarcinoma, Acinar Type",-30.0
326,292,TCGA-KC-A4BN,TCGA-KC-A4BN-01,55,0.0,-25.0,1815.0,-20392.0,0.0,59.67057895,0,0,0.0,No,8140/3,Yes,0.3244,0.0,20.0,,59.67057895,0:LIVING,5A468990-D76D-4C67-8437-62689B593AE2,N0,T2A,Tumor Free,59.67057895,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,Cornell Medical College,KC,0.666666667,"Prostate Adenocarcinoma, Acinar Type",-30.0
327,73,TCGA-EJ-5530,TCGA-EJ-5530-01,61,1.0,-41.0,1832.0,-22316.0,0.0,60.22947694,0,1,0.015,No,8550/3,Yes,0.2709,0.0,45.0,No,60.22947694,0:LIVING,e4a755e3-4938-4321-b5a9-27a445036791,N0,T2C,Tumor Free,60.22947694,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.566666667,"Prostate Adenocarcinoma, Acinar Type",-46.0
328,62,TCGA-EJ-5515,TCGA-EJ-5515-01,60,,-29.0,1832.0,-22097.0,0.0,60.22947694,0,1,0.0,No,8550/3,Yes,0.2903,0.01,12.0,No,60.22947694,0:LIVING,19cf56b2-a85b-43e7-971f-5680b9b1a67a,N0,T3A,Tumor Free,60.22947694,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.433333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
330,413,TCGA-VP-A87D,TCGA-VP-A87D-01,54,2.0,-37.0,1853.0,-19818.0,0.0,39.25436434,1,0,0.0953,No,8140/3,Yes,0.3234,0.0,48.0,No,60.91988033,0:LIVING,AA405B5F-F75D-486A-96F3-1DF7ADD18193,N1,T3A,Tumor Free,39.25436434,1:PROGRESSION,No,,No,-24.0,PRAD,No,Yes,Washington University,VP,1.7,"Prostate Adenocarcinoma, Acinar Type",-44.0
334,63,TCGA-EJ-5516,TCGA-EJ-5516-01,49,1.0,-33.0,1889.0,-17980.0,0.0,62.103429,0,1,0.0454,No,8550/3,Yes,0.258,0.0,23.0,No,62.103429,0:LIVING,1fd06207-54e0-4aba-819c-c7f671871f39,N0,T3A,Tumor Free,62.103429,0:CENSORED,No,White,No,-12.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.733333333,"Prostate Adenocarcinoma, Acinar Type",-30.0
335,64,TCGA-EJ-5517,TCGA-EJ-5517-01,55,0.0,-25.0,1889.0,-20422.0,0.0,62.103429,0,1,0.0327,No,8550/3,Yes,0.2528,0.0,19.0,No,62.103429,0:LIVING,4b9aa301-d2e3-47f3-b724-a34f420b2b6b,N0,T2C,Tumor Free,62.103429,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.633333333,"Prostate Adenocarcinoma, Acinar Type",-40.0
338,384,TCGA-V1-A9OL,TCGA-V1-A9OL-01,65,3.0,,1913.0,-24090.0,,3.452016964,1,0,0.2705,No,8140/3,Yes,0.3249,0.0,28.0,Yes,62.89246145,0:LIVING,FCBD7B29-12DA-44C8-B241-1388D1B15684,N0,T3B,,3.452016964,1:PROGRESSION,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.933333333,"Prostate Adenocarcinoma, Acinar Type",
339,346,TCGA-KK-A8IM,TCGA-KK-A8IM-01,55,1.0,,1915.0,-20425.0,0.0,62.95821416,0,0,0.0571,No,8140/3,No,0.3305,0.0,25.0,No,62.95821416,0:LIVING,4434864A-8A0D-488E-B9A7-6749719663E5,N0,T2C,Tumor Free,62.95821416,0:CENSORED,No,,No,,,No,Yes,MD Anderson Cancer Center,KK,0.833333333,"Prostate Adenocarcinoma, Acinar Type",
340,378,TCGA-V1-A9O5,TCGA-V1-A9O5-01,64,5.0,,1932.0,-23725.0,,4.076667653,1,0,0.259,No,8140/3,Yes,0.3292,0.0,37.0,Yes,63.51711214,0:LIVING,E0DFC37A-4A2E-4353-9673-241B100B3467,N1,T4,,4.076667653,1:PROGRESSION,No,,Yes,,PRAD,No,Yes,University of California San Francisco,V1,1.233333333,"Prostate Adenocarcinoma, Acinar Type",
341,372,TCGA-V1-A8WL,TCGA-V1-A8WL-01,64,1.0,-27.0,1948.0,-23725.0,,64.04313377,0,0,0.0359,No,8140/3,Yes,0.3343,0.02,25.0,No,64.04313377,0:LIVING,F7FC3F2E-C70E-460D-B34D-BB2EA423A0AE,N0,T3A,,64.04313377,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,University of California San Francisco,V1,0.833333333,"Prostate Adenocarcinoma, Acinar Type",-28.0
342,178,TCGA-G9-6498,TCGA-G9-6498-01,53,0.0,,1952.0,-19568.0,0.0,44.12006444,1,0,0.0109,No,8550/3,Yes,0.3274,0.0,19.0,No,64.17463918,0:LIVING,b8fbfe87-e92c-4d54-a620-17b2dcde6d53,,T3A,Tumor Free,44.12006444,1:PROGRESSION,No,,No,,PRAD,No,Yes,Roswell Park,G9,0.633333333,"Prostate Adenocarcinoma, Acinar Type",
343,66,TCGA-EJ-5519,TCGA-EJ-5519-01,64,4.0,-33.0,1962.0,-23669.0,0.0,64.5034027,0,1,0.1289,No,8550/3,Yes,0.2689,0.04,71.0,No,64.5034027,0:LIVING,5313a055-c2d7-4cbd-a8c1-57ac85912d89,N1,T3B,Tumor Free,64.5034027,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,2.333333333,"Prostate Adenocarcinoma, Acinar Type",-34.0
344,56,TCGA-EJ-5508,TCGA-EJ-5508-01,65,0.0,-35.0,1965.0,-23758.0,0.0,64.60203176,0,1,0.0136,No,8550/3,Yes,0.2577,0.0,21.0,No,64.60203176,0:LIVING,bd18dd01-d894-4bdd-9ce2-e25705a52a57,N0,T3A,Tumor Free,64.60203176,0:CENSORED,No,White,No,-16.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.7,"Prostate Adenocarcinoma, Acinar Type",-38.0
345,304,TCGA-KK-A59Y,TCGA-KK-A59Y-01,56,2.0,-17.0,1968.0,-20768.0,0.0,64.70066082,0,0,0.1105,No,8140/3,Yes,0.3093,0.0,23.0,No,64.70066082,0:LIVING,4C197D76-DAF6-474D-B561-DED42905F52A,N1,T3A,Tumor Free,64.70066082,0:CENSORED,No,,Yes,-22.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,0.766666667,"Prostate Adenocarcinoma, Acinar Type",-30.0
346,194,TCGA-HC-7078,TCGA-HC-7078-01,69,6.0,-27.0,1985.0,-25402.0,0.0,65.2595588,0,1,0.2282,No,8550/3,Yes,0.3139,0.0,30.0,No,65.2595588,0:LIVING,9f802576-1e98-496c-bda4-4b1dd2e411c8,N0,T3A,Tumor Free,65.2595588,0:CENSORED,No,White,No,-18.0,PRAD,No,Yes,International Genomics Consortium,HC,1.0,"Prostate Adenocarcinoma, Acinar Type",-24.0
348,150,TCGA-G9-6338,TCGA-G9-6338-01,61,0.0,,2028.0,-22360.0,0.0,66.67324194,0,1,0.1109,No,8550/3,Yes,0.2993,0.0,39.0,No,66.67324194,0:LIVING,2c48b1bf-4e49-4869-874b-f08787fa04b5,N0,T3A,With Tumor,66.67324194,0:CENSORED,No,White,No,,PRAD,No,Yes,Roswell Park,G9,1.3,"Prostate Adenocarcinoma, Acinar Type",
349,414,TCGA-VP-A87E,TCGA-VP-A87E-01,59,0.0,-21.0,2037.0,-21811.0,0.0,66.96912911,0,0,0.0,No,8140/3,Yes,0.3287,0.0,19.0,No,66.96912911,0:LIVING,DC20ECF0-2807-4675-A7FD-8EAD1CEE7EA0,N0,T2C,Tumor Free,66.96912911,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,Washington University,VP,0.666666667,"Prostate Adenocarcinoma, Acinar Type",-14.0
351,344,TCGA-KK-A8IK,TCGA-KK-A8IK-01,56,14.0,-11.0,2052.0,-20594.0,0.0,67.46227439,0,0,0.4633,No,8140/3,Yes,0.3476,0.14,28.0,,67.46227439,0:LIVING,D4F4DDC1-CFD7-4C57-ADE6-4F32CB7FFD85,N0,T2C,Tumor Free,67.46227439,0:CENSORED,No,,No,0.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,0.933333333,"Prostate Adenocarcinoma, Acinar Type",-8.0
353,158,TCGA-G9-6354,TCGA-G9-6354-01,55,3.0,,2066.0,-20403.0,0.0,67.92254332,0,0,0.0579,No,8550/3,Yes,0.3244,0.0,22.0,No,67.92254332,0:LIVING,6bbbe263-3632-4567-912c-95bc9940a1dd,,T2B,Tumor Free,67.92254332,0:CENSORED,No,,No,,PRAD,No,Yes,Roswell Park,G9,0.733333333,"Prostate Adenocarcinoma, Acinar Type",
354,149,TCGA-G9-6336,TCGA-G9-6336-01,57,,-23.0,2068.0,-20851.0,0.0,67.98829602,0,1,0.0001,No,8550/3,Yes,0.2877,0.0,15.0,No,67.98829602,0:LIVING,59207bcd-f127-481f-b576-8716da7d7d97,N0,,Tumor Free,67.98829602,0:CENSORED,No,White,No,-22.0,PRAD,No,Yes,Roswell Park,G9,0.5,"Prostate Adenocarcinoma, Acinar Type",-24.0
355,68,TCGA-EJ-5522,TCGA-EJ-5522-01,51,0.0,-35.0,2079.0,-18802.0,0.0,68.34993589,0,1,0.0245,No,8550/3,Yes,0.2546,0.0,14.0,No,68.34993589,0:LIVING,214884ef-a932-4fc3-b6ff-16ce5164da3e,N0,T2C,Tumor Free,68.34993589,0:CENSORED,No,White,No,-14.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.466666667,"Prostate Adenocarcinoma, Acinar Type",-34.0
357,154,TCGA-G9-6347,TCGA-G9-6347-01,59,0.0,,2089.0,-21721.0,0.0,68.67869941,0,0,0.0001,No,8140/3,Yes,0.3085,0.03,14.0,No,68.67869941,0:LIVING,b5268f49-2710-4d17-a78b-4a05412e8375,,T2C,Tumor Free,68.67869941,0:CENSORED,No,,No,,PRAD,No,Yes,Roswell Park,G9,0.5,"Prostate Adenocarcinoma, Acinar Type",
358,193,TCGA-HC-7077,TCGA-HC-7077-01,64,2.0,-27.0,2115.0,-23636.0,0.0,69.53348457,0,1,0.0626,No,8550/3,Yes,0.2945,0.01,48.0,No,69.53348457,0:LIVING,92252560-5984-41f6-a4b5-a3aa8654c0c8,,T3A,Tumor Free,69.53348457,0:CENSORED,No,Black or African American,No,-18.0,PRAD,No,Yes,International Genomics Consortium,HC,1.633333333,"Prostate Adenocarcinoma, Acinar Type",-34.0
361,309,TCGA-KK-A6E1,TCGA-KK-A6E1-01,57,7.0,-7.0,2198.0,-21063.0,0.0,72.26222178,0,0,0.2188,No,8140/3,Yes,0.342,0.07,22.0,,72.26222178,0:LIVING,DEB57BD8-545F-477A-9A86-6BC6DB257270,N1,T3B,Tumor Free,72.26222178,0:CENSORED,No,,Yes,-14.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,0.733333333,"Prostate Adenocarcinoma, Acinar Type",-22.0
363,67,TCGA-EJ-5521,TCGA-EJ-5521-01,63,0.0,-13.0,2279.0,-23304.0,0.0,74.9252063,0,1,0.0736,No,8550/3,Yes,0.2677,0.0,40.0,No,74.9252063,0:LIVING,d44d4bcb-beb1-4464-acd2-9972751f5018,N0,T3A,Tumor Free,74.9252063,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.333333333,"Prostate Adenocarcinoma, Acinar Type",-16.0
364,407,TCGA-VP-A875,TCGA-VP-A875-01,67,0.0,-29.0,2309.0,-24742.0,0.0,75.91149686,0,0,0.1832,No,8140/3,Yes,0.3324,0.0,28.0,No,75.91149686,0:LIVING,E833AD67-2CB3-414C-B15E-28F49479E2EF,N0,T3A,,75.91149686,0:CENSORED,No,,No,-24.0,PRAD,No,Yes,Washington University,VP,0.933333333,"Prostate Adenocarcinoma, Acinar Type",-36.0
366,104,TCGA-EJ-8468,TCGA-EJ-8468-01,63,0.0,-33.0,2347.0,-23371.0,0.0,77.16079824,0,0,0.0819,No,8550/3,Yes,0.312,0.0,21.0,No,77.16079824,0:LIVING,00b16434-0b3a-4194-8714-74dccbebe06c,N0,T3A,Tumor Free,77.16079824,0:CENSORED,No,,No,-18.0,PRAD,Yes,No,University of Pittsburgh,EJ,1.466666667,"Prostate Adenocarcinoma, Acinar Type",-36.0
368,153,TCGA-G9-6343,TCGA-G9-6343-01,62,1.0,,2450.0,-22843.0,0.0,80.5470625,0,1,0.0142,No,8550/3,Yes,0.2931,0.0,26.0,,80.5470625,0:LIVING,36b87d12-9f96-460f-a3b5-a4c08cbf5b07,,T2C,Tumor Free,80.5470625,0:CENSORED,No,White,No,,PRAD,No,Yes,Roswell Park,G9,0.833333333,"Prostate Adenocarcinoma, Acinar Type",
369,148,TCGA-G9-6333,TCGA-G9-6333-01,66,1.0,-21.0,2465.0,-24249.0,0.0,81.04020778,0,1,0.0463,No,8550/3,Yes,0.2902,0.0,30.0,No,81.04020778,0:LIVING,64bf32c9-9466-404a-a147-e7a0b9e91e34,N0,T2C,Tumor Free,81.04020778,0:CENSORED,No,White,No,-22.0,PRAD,No,Yes,Roswell Park,G9,1.866666667,"Prostate Adenocarcinoma, Acinar Type",-22.0
371,340,TCGA-KK-A8IG,TCGA-KK-A8IG-01,55,6.0,-19.0,2505.0,-20266.0,0.0,82.35526186,0,0,0.2051,No,8140/3,Yes,0.3341,0.0,30.0,No,82.35526186,0:LIVING,1E3C1D8F-B3C9-47BE-89E4-22E6B16ED2AE,N0,T3A,Tumor Free,82.35526186,0:CENSORED,No,,No,-22.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,1.0,"Prostate Adenocarcinoma, Acinar Type",-32.0
372,257,TCGA-HI-7170,TCGA-HI-7170-01,58,3.0,-23.0,2522.0,-21199.0,0.0,82.91415985,0,1,0.0428,No,8550/3,Yes,0.3233,0.0,25.0,No,82.91415985,0:LIVING,6394e00a-1f6f-4ea2-b885-373bbb59def9,N0,T2C,Tumor Free,82.91415985,0:CENSORED,No,White,No,-20.0,PRAD,No,Yes,Fox Chase,HI,0.866666667,"Prostate Adenocarcinoma, Acinar Type",-22.0
374,80,TCGA-EJ-7218,TCGA-EJ-7218-01,71,0.0,-25.0,2542.0,-26181.0,0.0,83.57168689,0,0,0.0499,No,8550/3,Yes,0.3217,0.0,24.0,No,83.57168689,0:LIVING,d7763066-fb06-4519-9188-5de7dd12fdb7,N0,T2C,Tumor Free,83.57168689,0:CENSORED,No,,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,0.8,"Prostate Adenocarcinoma, Acinar Type",-26.0
375,151,TCGA-G9-6339,TCGA-G9-6339-01,58,2.0,,2551.0,-21305.0,0.0,53.71995923,1,0,0.0368,No,8550/3,Yes,0.318,0.0,38.0,No,83.86757405,0:LIVING,d39d1a49-fcc0-4f2c-9338-df904e7f6a09,N0,T3B,Tumor Free,53.71995923,1:PROGRESSION,No,,No,,PRAD,No,Yes,Roswell Park,G9,1.266666667,"Prostate Adenocarcinoma, Acinar Type",
376,360,TCGA-QU-A6IP,TCGA-QU-A6IP-01,66,0.0,-31.0,2620.0,-24212.0,0.0,86.13604235,0,0,0.0021,No,8140/3,Yes,0.2956,0.0,14.0,No,86.13604235,0:LIVING,9A8E27C9-614B-491F-913D-429DFC4E2C4D,N0,T2A,,86.13604235,0:CENSORED,No,,No,-26.0,PRAD,No,Yes,Harvard Beth Israel,QU,0.433333333,"Prostate Adenocarcinoma, Acinar Type",-30.0
378,77,TCGA-EJ-7115,TCGA-EJ-7115-01,65,1.0,-33.0,2687.0,-23986.0,0.0,88.33875793,0,1,0.0616,No,8550/3,Yes,0.3155,0.0,40.0,No,88.33875793,0:LIVING,c606918f-e8c0-4019-ad6f-47d5cd7615c4,N0,T3A,Tumor Free,88.33875793,0:CENSORED,No,White,No,-22.0,PRAD,Yes,No,University of Pittsburgh,EJ,2.033333333,"Prostate Adenocarcinoma, Acinar Type",-44.0
379,411,TCGA-VP-A87B,TCGA-VP-A87B-01,63,2.0,-23.0,2722.0,-23271.0,0.0,89.48943025,0,0,0.1284,No,8140/3,Yes,0.3227,0.0,36.0,Yes,89.48943025,0:LIVING,17C0CE0F-8227-4119-9B39-EA8DB18F5F4B,N0,T2B,Tumor Free,81.3032186,1:PROGRESSION,No,,Yes,-22.0,PRAD,No,Yes,Washington University,VP,1.2,"Prostate Adenocarcinoma, Acinar Type",-22.0
381,79,TCGA-EJ-7125,TCGA-EJ-7125-01,44,0.0,-25.0,2850.0,-16425.0,0.0,93.69760331,0,1,0.0036,No,8550/3,Yes,0.3004,0.0,89.0,No,93.69760331,0:LIVING,aca312ab-6dbd-4183-8b22-8f37834f3426,N0,T2C,Tumor Free,93.69760331,0:CENSORED,No,White,No,-20.0,PRAD,Yes,No,University of Pittsburgh,EJ,5.366666667,"Prostate Adenocarcinoma, Acinar Type",-40.0
382,380,TCGA-V1-A9O9,TCGA-V1-A9O9-01,56,1.0,,2870.0,-20805.0,,94.35513036,0,0,0.0731,No,8140/3,Yes,0.3216,0.0,26.0,No,94.35513036,0:LIVING,F6935F67-5C62-4774-8346-711F36F3B547,N0,T3B,,94.35513036,0:CENSORED,No,,No,,PRAD,No,Yes,University of California San Francisco,V1,0.866666667,"Prostate Adenocarcinoma, Acinar Type",
385,408,TCGA-VP-A876,TCGA-VP-A876-01,46,2.0,-29.0,3333.0,-16934.0,0.0,109.5768814,0,0,0.0688,No,8140/3,Yes,0.3195,0.0,20.0,No,109.5768814,0:LIVING,75D22D59-DEC8-4F59-86C8-36B5E9F4FB0D,N0,T2C,Tumor Free,109.5768814,0:CENSORED,No,,No,-14.0,PRAD,No,Yes,Washington University,VP,0.666666667,"Prostate Adenocarcinoma, Acinar Type",-30.0
389,312,TCGA-KK-A6E4,TCGA-KK-A6E4-01,69,0.0,,2753.0,-25338.0,0.0,115.1329848,0,0,0.1139,No,8140/3,Yes,0.3064,0.0,29.0,,115.1329848,1:DECEASED,DCF383D5-B25A-4EA9-A3F4-4D7EA5DDD9EF,N0,T2B,Tumor Free,115.1329848,0:CENSORED,No,,No,,PRAD,No,Yes,MD Anderson Cancer Center,KK,0.966666667,"Prostate Adenocarcinoma, Acinar Type",
390,406,TCGA-VP-A872,TCGA-VP-A872-01,60,4.0,-9.0,3631.0,-22098.0,0.0,119.3740343,0,0,0.1414,No,8500/3,Yes,0.3341,0.02,26.0,No,119.3740343,0:LIVING,7FC65E49-0401-4A36-8800-FD87B7927FC1,N0,T3A,Tumor Free,119.3740343,0:CENSORED,No,,No,-12.0,PRAD,No,Yes,Washington University,VP,0.866666667,"Prostate Adenocarcinoma, Other Subtype",-12.0
391,358,TCGA-QU-A6IN,TCGA-QU-A6IN-01,61,0.0,,4264.0,-22286.0,0.0,140.1847651,0,0,0.0354,No,8140/3,Yes,0.3265,0.0,20.0,No,140.1847651,0:LIVING,D07D20F4-DD65-4FFC-ADD4-01F350CA7B65,N0,T2C,Tumor Free,140.1847651,0:CENSORED,No,,No,,PRAD,No,Yes,Harvard Beth Israel,QU,0.666666667,"Prostate Adenocarcinoma, Acinar Type",
393,310,TCGA-KK-A6E2,TCGA-KK-A6E2-01,54,0.0,-33.0,5024.0,-19974.0,0.0,165.1707927,0,0,0.0154,No,8140/3,Yes,0.3365,0.02,35.0,,165.1707927,0:LIVING,56C88739-C076-42CC-A2CB-FD613AB567B5,N0,T2C,Tumor Free,165.1707927,0:CENSORED,No,,No,-18.0,PRAD,No,Yes,MD Anderson Cancer Center,KK,1.2,"Prostate Adenocarcinoma, Acinar Type",-48.0
